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Abstract 
The synthesis of six P-orcinol depsides and their comparison with the naturally 
occurring depsides isolated from a new Ecuadoran Erioderma lichen species was 
effected. These depsides, methyl eriodermate (92), methyl 2-0-eriodermate (93) , 
methyl 4-0-methyleriodermate (94), methyl 2'-0-methyleriodennate (95), methyl 
2,2'-di-O-methyleriodennate (96) and methyl 5-chloronorobtusatate (98) proved to 
be identical in all respects with the naturally occurring metabolites. 
A chemosyndrome of fully substitutedpara-depsides based on phenarctin (131) 
and pseudocyphellarin A (77) had been detected in Pseudocyphellaria pickeringii. 
The structures of five new depsides in this lichen, namely 2'-0-methyl-
pseudocyphellarin A (134), 2'-0-methylphenarctin (135), isopseudocyphellarin 
(136), 2'-0-methylisopseudocyphellarin (137) and 1 '-chloronephroarctin (138) have 
been established by unambiguous synthesis in the present work and their natural 
occurrence confirmed by chromatographic and spectroscopic comparisons. 
The para-sphaerophorol lichen depsides, 4-0-demethylsphaerophorin (149), 
isophaeric acid (150), hyperlatolic acid (151) and isohyperlatolic acid (152) have 
been prepared by total synthesis .for the first time. Chromatographic comparisons 
confirmed the occurrence of sphaerophorin (148) and 4-0-demethylsphaerophorin 
(149) in Sphaerophorus melanocarpus, of (148) and isosphaeric acid (150) in 
Dimeleana oriena and of hyperlatolic acid (151) and isohyperlatolic acid (152) in 
Fuscidea viridis. 
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Chapter 1 
General Introduction 
Lichens are a unique form of plant life, composed of two distinctly unlike 
organisms, a fungus (the mycobiont) and an alga or cyanobacterium (the phytobiont) 
living in symbiotic association as a new, composite organism. This resulting organism is 
a distinct, long-lived plant, quite different from either component. 1 The symbionts are so 
closely bound that the fungal cells completely envelope or penetrate the algal cells. In the 
great majority of lichens the mycobiont is an Ascomycete,2 while the photobiont is either 
a cyanobacterium or a green alga. Most of the symbionts which form lichens have not 
been found as free-living organisms. 
Lichens are the most advanced form of symbiosis and their properties (chemical, 
physiological and morphological) differ from those of either individual symbiont. 
Lichens are relatively long-lived compared to most free-living fungi and algae. Most 
lichens are tolerant of low moisture conditions while both the symbionts need moisture. 
Fungi prefer shade and algae sunlight, while lichens may grow in either full sunlight or 
deep shade. Morphologically, the fungal hyphae change on combination with the 
phytobiont, and protective devices against moisture loss through transpiration and high 
light intensity are formed, as well as new supporting structures and reproductive organs. 
13c labelling experiments have shown that the photosynthesis is carried out by the 
photobiont, 1 which supplies the mycobiont with the soluble carbohydrates for 
metabolism. The lichen association produces many primary and secondary metabolites. 
Most of the secondary metabolites do not occur in other plants, the isolated mycobiont or 
photobiont, but only in the lichen. 
Ecological Role of Lichen Metabolites 
Many of the secondary lichen metabolites are thought to play significant ecological 
roles,3 four of which seem reasonably well established. Lichen pigments may function as 
light-screening compounds and protect the photobiont from strong solar light. The 
2 
pigment usnic acid (1) acts in this way, its concentration in Cladonia subtenuis increasing 
with the light intensity, a does the pigment parietin (2) in Xanthoria parietina.3 
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Secondly, certain metabolites may promote the chemical weathering of rocks by 
acting as complexing agents for metal ions. Metal ion complex formation is known to be 
an important soil-forming aspect of biochemical weathering. Phenolic acids present in 
lichens can function as ligands to form· metal ion complexes. Complexes of calcium, 
magnesium, iron, aluminium and copper ions are known.4 
Secondary lichen compounds have also been known to inhibit the growth of many 
fungi. This allelopathic action can be important ecologically, e.g. the growth of Pinus 
sylvestris seedlings is inhibited by both perlatolic (3) and usnic (1) acids, which restrict 
the development of mycorhizal fungi that benefit the growth of the seedlings. 
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Finally, lichen substances can act as antiherbivore defense compounds. Vulpinic 
acid derivatives, terpenes, anthraquinones, certain depsides [e.g. diffractaic acid (4)] and 
depsidones, [e.g. fumarprotocetraric acid (5) and salazinic acid (6)], all deter predation, 
either because of their toxicity or due to their unattractive taste. 
HO 
HO 
CHO 
(5) 
Me o 
CHO 
H 
HO 
(6) 
0 
0 
E 
CH2C02CH== CHC02 H 
OH 
OH 
3 
Thus the ecological roles of secondary lichen metabolites may affect the success of 
certain lichen species in establishing themselves in particular environments, hence 
influencing the geographical distribution as well as the diversity and structure of certain 
natural lichen communities. 
Man's Use of Lichen Metabolites 
Lichens have been used by man for centuries:2 as a source of food, in dyestuffs, 
medicine and perfumery; all of which are still used today. 
An abundant conifer lichen, Bryoriafremontii, has been harvested for famine relief 
by Indian tribes in western North America. The lichen is soaked to leach out the bitter 
components, cooked, dried and then cut into loaves, which are soaked in water before 
eating. Today the Japanese eat several Urnbilicaria species (rock tripe) as a delicacy. 
However it will never be possible to harvest lichens on a large enough scale for 
continuous human food con un1ption as they grow too slowly. 
4 
Lichens form an important component in the winter food of reindeer and caribou in 
the Northern Hemisphere. The recent radioactive fallout from the USSR nuclear reactor 
breakdown has led to high radioactive levels in the lichens in northern Scandinavia. Due 
to the slow growth of lichens these levels will persist for much longer than in more usual, 
quick growing crops. This has proved a disaster indeed for the Lapplanders, who 
harvest the lichens for storage as fodder for reindeer, as well as allowing direct grazing. 
It has been suggested that the "manna" described in the Old Testament may in fact 
have been a desert lichen Lecanora esculenta, which still is grazed by sheep in Libya. 
Lichens also serve as food for invertebrates. 
-
Lichens have formed part of traditional medicines for thousands of years: in Egypt, 
Pseudevernia furfuracea is still used in herbal medicine after nineteen thousand years; 
while in Sweden diabetes, lung diseases and catarrh are still treated with preparations of 
Cetraria islandica (Iceland Moss), as has been done in Europe for centuries. Usnea 
longissima was used in China as an expectorant and also to cure ulcers, while in India 
liver complaints were treated with Peltigera canina. In Finland different lichen species 
have been used in the treatment of jaundice, pulmonary tuberculosis, infected wounds, 
acne, toothache and sore throats. However it is not known for certain what active 
ingredients caused the reported "cures". 
C5H11 0 OH H02C II 
H--- C-0 C02H 
H 
C13H27 
0 McO OMe HO C5H11 
(7) (8) 
When lichens were first screened for biological activity in the nineteen forties, it 
was found that extracts from over fifty lichen species in eastern North America alone 
inhibited the growth of certain gram-positive bacteria.5 Several lichen substances, 
including usnic acid (1) and prolichesterinic acid (7), proved to be powerful antibiotic 
agents,6 but, as there were undesirable side-effects, they are no longer used medicinally. 
5 
Today new lichen metabolites are still screened for their anti-tumour effects on humans as 
well as for their antibiotic and anti-fungal activity.2 One compound, 4-0-methylcrypto-
chlorophaeic acid (8) is used as an anti-inflammatory agent. 
Lichens have been used as dyestuffs from very early times- Roccella montagnei 
was used to provide a purple dye in the Mediterranean region and Letharia vulpina a 
yellow dye in North America. Many amateur weavers still use lichen dyes, an 
undesirable activity according to conservationists, as the lichens grow far too slowly for 
easy regrowth. 
Lichen extracts are used commercially in the perfume industry. Evernia prunastri 
(oak moss), from Yugoslavia and Morocco, and Pseudevernia furfuracea (tree moss), 
from southern France, are widely used. The extract of essential oils and depside 
derivatives is used both as a scent and as a fixative. As this extract gives a heavy 
"mossy" odour if it is used as the main ingredient, it is used principally as a base for other 
perfumes.7 
Lichen Metabolites 
Lichens produce a large number of compounds which can be divided into two 
broad groups: the primary and the secondary metabolites. The primary metabolites are 
broadly distributed and include common proteins, amino acids and carbohydrates. On the 
other hand the secondary metabolites do include many compounds unique to lichens -
furthermore they have rarely been found in the individual photobiont or mycobiont when 
these are cultured separately. These secondary metabolites usually occur as crystalline 
deposits on the outside of the cell walls of the fungal hyphae and include aliphatic acids, 
phenolic acids and triterpenes. 
Me 
C0-0 
HO OH 
Me (9) 
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Since the majority of primary metabolites investigated so far are non-specific to 
lichens, they have not been subjected to such detailed scrutiny as the secondary 
metabolites. Chemists have been interested in lichen secondary metabolites since last 
century, at first because of their unique structures but latterly because of their biological 
activity and chemotaxonomic importance. Zopf8 and Hesse9 were the first major 
investigators, publishing classifications early this century which were based on the 
properties and empirical formulae of the lichen substances. In 1913 Emil Fischer10 
carried out the first chemical synthesis of a lichen metabolite, the depside lecanoric acid 
(9). Asahina11 and his co-workers in Japan have carried out extensive studies on the 
structure of lichen substances: they proposed a classification of these compounds based 
on a knowledge of their chemical structures and biosynthetic pathways. During the last 
four decades lichen substances have been investigated by a number of workers -
including Culberson, Elix and Huneck - thereby greatly increasing our knowledge of their 
properties. The classification of lichen secondary metabolites based on their biosynthetic 
origin, as proposed by Asahina and modified by Culberson,12 is outlined below. 
1. Mevalonic Acid Pathway: 
1. Sterols; e.g. lichesterol (10). 
2. Terpenes; e.g. leucotylin (11). 
2. Shikimic Acid Pathway: 
1. Terphenylquinones; e.g. polyphoric acid (12). 
2. Pulvinic acid derivatives; e.g. vulpinic acid (13). 
3. Acetate-Polymalonate Pathway: 
1. Higher aliphatic acids and esters; e.g. rocce-llic acid (14). 
2. Phenolic carboxylic acid derivatives; 
(a) Monocylic derivatives; e.g. orsellinic acid (15). 
(b) Bi- or polynuclear aromatic compounds; 
(i) orcinol derivatives: 
depsides; e.g. lecanoric acid (9). 
depsidones; e.g. colensoic acid (16). 
depsones; e.g. picrolichenic acid (17). 
dibenzofurans; e.g. melacarpic acid (18) . 
diphenyl ethers; e.g. leprolomin (19). 
(ii) J3-orcinol derivatives: 
depsides; e.g. hypothamnolic acid (20). 
depsidones; e.g. constictic acid (21 ). 
benzyl esters; e.g. barbatolic acid (22). 
(iii) phloroglucinol derivatives: e.g. usnic acid (1 ). 
(c) Aromatic compounds derived from a single polyketide chain: 
chromones; e.g. sordidone (23) 
xanthones; e.g. lichexanthone (24). 
anthraquinones; e.g. parietin (2). 
napthoquinones; e.g. haemoventosin (25) 
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The Structure of Depsides 
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A depside has primarily a phenyl benzoate structure i.e. it is composed of a phenol 
and a benzoic acid moiety linked by a depside ester bond._ The numbering of the depside 
ring system is shown below (26). 
C0-0 
HO OH 
(26) 
1 0 
Depsides, which form the largest group of lichen metabolites, exhibit a number of 
structural variations, examples of which are discussed below. 
In orcinol para-depsides (26) the depside ester bond involves a hydroxy group 
in the 4'-position on the B-ring (i.e. para to the carboxylic acid function) esterified by a 
carboxylic acid group on the A-ring. These para-depsides may have unbranched side 
chains in the 6 and 6' positions (R 1 R2 = methyl, propyl, pentyl, heptyl or nonyl), [ e.g. 
' 
anziaic acid (27)], formed via the acetyl-polymalonate pathway as shown below. Some 
compounds, [e.g. 4-0-methylolivetoric acid (28)], have pentyl, heptyl, or nonyl side 
chains with a carbonyl group at the P-position, which are also of acetate-polymalonate 
origin. Additional hydroxy or chloro substituents are sometimes observed in the 3- and 
5-positions [e.g. 3,5-dichloro-2'-0-methylanziaic acid (29)] while hydroxy and carboxy 
groups are commonly methylated [e.g. isohyperlatolic acid (30)]. 
C0-0 
C0-0 
HO OH 
(27) McO OH 
(28) 
Cl C0-0 OMe C0-0 
OH OH 
Cl 
(29) (30) 
Esterification of a para-depside with a third orsellinic acid unit gives rise to the 
tridepsides [e.g. gyrophoric acid (31)]. 
Mc Mc 
C0-0 OH 
HO OH C0-0 
Me 
(31) 
In orcinol meta-depsides (32) [e.g. 4-0-methylcryptochlorophaeic acid (8)] the 
carboxylic acid group of the A-ring is esterified by a hydroxy group in the 3'-position on 
the B-ring (i.e. meta to the carboxylic acid function). All such depsides have propyl or 
pentyl side chains, and may have some or all of the free hydroxy groups methylated. 
HO 
C0-0 
OH HO 
(32) 
OH 
R1, R2 = C3H7 or C5H 11 
P-Orcinol para-depsides, [e.g. 4-0-demethylbarbatic acid (33)], orcinol 
P-orcinol para-depsides, [e.g. 3'-methylevernic acid (34)], and P-orcinol orcinol 
para-depsides, [e.g. 2-0-methylobtusatic acid (35)], all contain an extra carbon at the 3-
and/or the 3'-positions, and involve the participation of one or two P-orsellinic acid 
moieties in depside fonnation. 
Me Me Me 
C0-0 C0-0 
HO OH OH 
Me Me Me 
(34) 
(33) 
1 2 
Me 
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McO OMe 
Me Me 
(35) 
Hypothamnolic acid (20) is an example of a P-orcinol meta-depside. Here the 
3'-position is occupied by a methyl group so the depside ester linkage involves a 
5'-hydroxy group. 
Chemosyndromic Variation 
A chemosyndrome is a term used for a group of biosynthetically related 
metabolites. 13 In this pattern of chemical variation, the major metabolite (or metabolites) in 
one species is always accompanied by minor quantities of several biosequentially related 
substances, which in turn are observed as major metabolites in related taxa. For example, 
the chemical variation among a chemosyndrome of P-orcinol depsides 14 produced by a 
group of Xanthoparmelia in North America has been observed to be due to different levels 
of oxidation in the c1 -substituent at position 3 as well as to the degree of 0-and 
C-methylation. These depsides barbatic acid (36), 3-a-hydroxybarbatic acid (37), 
baeomycesic acid (38), squamatic acid (39), 4-0-demethylbarbatic acid (33), diffractaic 
acid (40) and 2-0-methylobtusatic acid (34) are produced in varying quantities. 
Me Me 
Me Me 
C0-0 OH 
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McO OH C02H McO OMc C02 H 
· R Mc 
Me Mc 
(36) R=Me (40) (37) R=CH20H 
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Biosynthcsis of Secondary Lichen Metabolites 
Compounds which are unique to lichens are mainly derived from the 
acetate-polyn1alonate pathway. These compounds are formed from two or three aromatic 
phenolic building blocks linked either by esterification, and/or by apparent oxidative 
coupling. The most common lichen metabolites; depsides, depsidones, dibenzofurans, 
depsone and usnic acids - are produced this way. The aron1atic building blocks are of three 
types: orcinol units, ~-orcinol units and phloroglucinol units. Although orsellinic acid 
(15) occurs in the free form in moulds and rarely in lichens, condensed derivatives, where 
two or three units are combined, are extremely common in the latter and, indeed, are the 
principal structural units of the most characteristic lichen products. 
The common feature distinguishing these characteristic lichen products from 
structurally similar compounds (which are more widely distributed) seems to be the 
intermolecular esterification or coupling of two or more of the phenolic units during 
biosynthesis. Xanthones, chromones and anthraquinones, which also originate via the 
acetate-polymalonate pathway are polycyclic aromatic compounds biosynthesized by 
intramolecular cyclization of a single, folded polyketide chain. 
The elaboration of the primary phenolic building blocks 12 is thought to occur in a 
sin1ilar manner to the biosynthesis of lipids, by synthesis of a key, intermediate, linear 
polyketide bound on a large fatty-acid synthetase complex. Birch's15 tracer work with 14c 
labelled acetate in the 1950's defined the origin of 6-methylsalicylic acid in Penicillium sp. 
and formed the foundation for future work on the biosynthetic origin of all polyketides, 
including that of the characteristic lichen compounds. 
Orsellinic Acid and Analogues 
Mosbach et al. 16•17 have shown (Scheme 1) that orsellinic acid (15) is formed in a 
similar way to 6-methylsalicylic acid by the condensation of an enzyme-bound acetyl-CoA 
starter unit (41) with three units of malonyl-CoA (42) to form the hypothetical intermediate, 
3,5,7-triketo-octanoic acid (43), which then undergoes internal aldol condensation, 
dehydration and hydrolysis. 
This hypothetical linear polyketide (43) could actually undergo cyclization in three 
0 
HO 
SCHEME I 
0 
II f-;: 
,-;(C-CJ 
CH2 
(41) 
/ 
0 
II 
C-0-
+2 CH2 
0 
" C-SCoA 
0~ (42) 
" C-SCoA f 
(42) 
0 0 
II II 
H3C- C- CH2- C- SCoA 
(46) 
0 0 0 0 
II II II II 
H3C-C- CH2- C- CH2- C- CH2- C- SCoA 
Me 0 
0 
(43) 
II 
C-SCoA 
0 
1 
Aldol 
condensation 
Mc 
(15) 
HO 
SCHEI\1E2 
Me 0 
0 
(43) 
SCoA 
Claisen 
condensation 
OH 
(44) 
OH 
(43) 
0 
HO 
Mto 0 
·} 
C 
I 
SCoA 
0 
(43) 
Aldol 
condensation 
OH 
(45) 
1 4 
·-
CH 3 
I 
C==O 
I 
CH 2 
I 
+ 
NADPH +H 
(i) 
O=C-SCoA 
(46) 
C3H7 
I 
O==C-SCoA 
(48) 
SCHEME3 
CH3 
I 
CHOH 
I 
CH2 
I 
O=C-SCoA 
(ii) 
(i) (ii) (iii) 
+ 
H02C-CH2 
I 
O== C-SCoA 
(42) 
C7H1s 
I 
O=C-SCoA 
(49) 
+ 
(42) 
Aldol 
condensation 
(49) 
... 
0 
C7H1s 
C02H 
HO OH 
(47) 
CH3 
I 
CH 
II 
CH 
I 
O==C-SCoA 
NADPH +H+ 
(iii) 
CH3 
I 
CH2 
I 
CH2 
I 
1 5 
O=C-SCoA 
(48) 
CsH11 
I (i) (ii) (iii) CH2 
I 
CH2 
I 
O=C-SCoA 
(50) 
0 
1 6 
alternative ways (Scheme 2): an aldol-type condensation giving orsellinic acid (15); a 
Claisen-type condensation leading to phloroacetophenone (44); or an alternative aldol-type 
condensation forming 3,5-dihydroxyphenylacetic acid ( 45). Orsellinic acid ( 15) and 
analogues are the precursors of depsides, depsidones and dibenzofurans, while the second 
route leads to usnic acid (1) and its derivatives. The compounds (15) and (44) have been 
found in lichens and fungi, but ( 45) has been found only in higher plants. The intermediate 
(43) is thought to be bound to a multi-enzyme complex rather than to co-enzyme A during 
the cyclization. 
Thus orsellinic acid ( 15) is formed by internal aldol condensation of an 
eight-membered carbon chain, while keto-acids with ten, twelve or fourteen carbon atoms 
give rise to homologues of orsellinic acid with three-, five- or seven-membered carbon side 
chains respectively. Scheme 3 illustrates the biosynthetic route to one of these compounds, 
namely 2-heptyl-4,6-dihydroxybenzoic acid (47). This compound arises by utilizing an 
alternative starter unit (50) containing eight carbon atoms and which may be formed by the 
consecutive addition of malonyl-coenzyme A and reduction sequences as shown. 
Alternatively the starter unit (50) could arise by degradation of the longer chain fatty 
acids already present in the lichen. Thus the P-oxidation of oleic acid (51) (Scheme 4) may 
lead to heptanoic acid (52), the precursor for the formation of (50). As a consequence of 
the biosynthetic origin, the alkyl side chains present in depsides and depsidones always 
contain one, three, five, seven or nine carbon atoms but never an even number. 
SCHEME4 
+ H02C(CH:J6C02H 
(51) (52) ! 
CJC02H 
The longer alkyl side chains (C5, c7, C9) often contain a carbonyl group P- to the 
aromatic ring. Such side chains probably result from incomplete reduction of the starter 
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unit prior to elaboration and subsequent cylization. 
The aromatic nuclei of the depsides and depsidones sometimes possess additional 
substituents including methyl, hydroxy, chloro, formyl and carboxy groups in the vacant 
3- and 5-positions which cannot have arisen via the acetate-polymalonate pathway. The 
biosynthetic origin of these substituents will now be discussed. 
P-Orcinol Units 
The C1-substituents (CH3, CH20H, CHO, C02H) commonly observed at the 
3-position in P-orsellinate units derive from S-adenosylmethionine and are probably 
introduced prior to cyclization of the linear polyketide (43) 18 as a methyl group under the 
influence of a transmethylase enzyme. 
CH3 
*o* 
HO 
H* 
HO 
Labelling pattern in the depsides lecanoric acid and atranorin after 
incubation with CH314C02H(*) and H 14C02H(") 
CH3 
* * co-o OH co-O 
*o* 
* OH C02H HO OH 
CH3 CHO 
" (9) (53) 
CH3 CH3 
C02H H* C02H 
0 
OH HO OH HO 
H* CH3 
(54) (55) 
" CH3 
OH 
* 
" C02CH3 
CH3 
CH3 
C02H 
OH 
CH3 
(56) 
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Studies by Yan1azaki et al. 19,20 in which the thallus of Parmelia tinctorum wa s 
sprayed with 14c-labelled acetic and 14c-labelled formic acid confirmed specific 
incorporation of the formic acid in the 3-CHO and 3'-CH3 groups of the depside atranorin 
(53). As expected the acetate was incorporated into both atranorin (53) and lecanoric acid 
(9). Subsequently it was shown that 3H-labelled orsellinic acid (54) and 3H-labelled 
P-orsellinic acid (55) were incorporated into lecanoric acid (9) and into atranorin 
respectively but incorporation of (54) into atranorin or (55) into lecanoric acid (9) was not 
observed. These results imply that the insertion of the c 1 -unit occurs before aromatization. 
Presumably the Ci-unit at the 3-position of P-orsellinic acid (56) is always added in 
the fully reduced state (i.e. as a methyl group). Other P-orcinol units differ in the degree of 
oxidation of added or the acetyl derived c 1 -substituents. 
S-adenosylmethionine is also involved in the methylation of carboxy or hydroxy 
groups to give the corresponding methyl esters and 0-methoxy groups found so often 
among the depsides. 
The hydroxy and chloro groups, by contrast, can apparently be added to the 
preformed aromatic nuclei of the depside or depsidone. Circumstantial evidence for such is 
provided by the common co-occurrence of the depsides, lecanoric acid (9) and 
diploschistesic acid (57) and of atranorin (53) and chloroatranorin (58). The addition of 
such substituents (Cl, OH) possibly involves participation of a peroxidase enzyme, but the 
details of such substitution mechanisms in lichens are unknown. 
Me Me Me 
C0-0 OH R C0-0 OH 
HO OH C02H HO OH C02H 
R Me CHO Me 
(9) R = H (53) R = H 
(57) R = OH (58) R = Cl 
The first biosynthetic investigation 1 of a depside was carried out with gyrophoric 
acid (31) from Umbilicaria papulosa. [l,3-1 4CJdiethyl- malonate was shaken with the 
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lichen thallus for three days, after which it was found that 4% of the radioactivity had been 
incorporated into the gyrophoric acid (31 ). Subsequent hydrolysis of this gyrophoric acid 
(31) catalysed by orsellinate depside hydrolase, followed by decarboxylation (catalysed by 
orsellinate decarboxylase), showed the same specific activity for all three orsellinic acid 
molecules. This activity occurred mainly in positions originating from the malonyl-SCoA 
and much less in positions derived from the acetyl-SCoA starter units (Scheme 5). This 
evidence confirmed that the normally accepted acetate-polymalonate pathway was operative 
in the biosynthesis of this para-depside. 
Mc-COSCoA + 
Me 
* C0-0 
HO OH 
Mc 
HO 
SCHEMES 
Me 
(31) 
) 
OH 
* C0-0 
decarbox ylase 
.. 
HO 
OH 
... 
HO 
Me 
* C02H 
* 
COSCoA 
OH 
depside hydrolase 
H 20 
Me 
Me 
OH 
While all depsides are formed by the intermolecular condensation of two moles 
of orsellinic or ~-orsellinic acid uni s, orcinol para-depsides (26) involve the bonding 
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of the hydroxy group in the 4'-position on the B-ring (i.e. para to the carboxylic acid 
function) with the acid group on the A-ring. This biosynthesis of the depside ester linkage 
is not fully understood. 1 The fungal component is believed to contain the enzyme 
responsible for the synthesis of the monocyclic units and may also effect their subsequent 
coupling. Alternatively, the algal partner may enzymatically condense the monocylic units, 
thought to be present as activated orsellinoyl-SCoA esters. However, it is possible that the 
total process could occur in the fungus on a single multi-enzyme complex composed of two 
to four orsellinic acid synthetase complexes associated in some way permitting direct 
condensation of the enzyme-bound monomers. 
Until recently it was believed that orcinol meta-depsides (32) were formed by 
the condensation of a 3'-hydroxy group (i.e. meta- to the carboxylic acid function on the B-
ring) with the acid group on the A-ring. However as this 3 '-hydroxy group is not formed 
directly in the acetate-polymalonate pathway to such precursors, additional steps must be 
involved in the biosynthesis of meta-depsides by comparison with that in para-depsides. 
Culberson 12 suggested that meta-depsides could be formed either by hydroxylation of the 
mononuclear aromatic B-ring precursor followed by intermolecular esterification; by a 
radical initiated rearrangement of a para-depside; or by direct attack of a carboxylate radical 
at the meta-position of the B-ring precursor. Although some para-depsides are known to 
contain an additional hydroxy group in the A-ring [e.g. (57)] not implicit in the 
acetate-polymalonate pathway, none have been isolated with an additional hydroxy group 
in the B-ring. After observing the rapid equilibration of the isomers para-scrobiculin (59) 
and meta-scrobiculin (60), Gaul and Elix21 recently proposed that meta-depsides are 
probably biosynthesized by hydroxylation of the B-ring of a para-depside, followed by 
rapid intramolecular rearrangement to the thermodynamically more stable meta-depside. 
Thus 4'-0-demethylsekikaic acid (60) would be formed from methyl divaricatate (61) as 
outlined in Scheme 6. This may well explain the common co-occurrence of divaricatic acid 
(62) and sekikaic acid (63) in several Ramalina species. 
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Depsidones 
The depsidones comprise the second largest group of lichen substances and are 
formed from two orsellinic acid (15) or ~-orsellinic acid (56) units. Previously it was 
thought that the biosynthesis of these compounds involved the oxidative coupling of 
depsides22 but subsequently Sala and Sargent23 proposed that they were probably derived 
by the oxidative coupling of a benzophenone followed by hydrolytic rearrangement to the 
depsidone as outlined in Scheme 7. 
SCHEl\1E 7 
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-2H OH OH 
HO HO OH HO 
0 
R R 0 
OH 
C02H OH Cycli:zation 0 
HO C02H HO 0 
OH 
0 
R 
R C02H 
However, in 1987, Elix, Jenie and Parker24 proposed that the hydroxylation of the 
5'-position of a para-depside, followed by acyl migration to a meta-depside, and 
ubsequent Smiles rearrangement could lead to the corresponding orcinol depsidones as 
illustrated in Scheme 8. This proposal seemed reasonable since the co-occurrence of 
isostructural depside-depsidone pairs are quite common whereas the benzophenones and 
grisadienones invoked in the Sala and Sargent proposal have not been observed to occur 
naturally in lichens. Jenie24 was successful in carrying out such a biomimeric synthesis of 
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divaronic acid (64) and stenosporonic acid (65) in the laboratory. 
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A summary of the currently accepted biosynthetic pathways to the common lichen 
metabolites24 is illustrated in Scheme 9. 
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Usnic acid ( 1) and its derivatives are formed from the alternative 
C-methylphloroacetophenone (66) units by oxidative coupling22 as shown in Scheme 10. 
Here again addition of a C1 -unit to the Cg polyketide intermediate (43) is assumed to 
involve S-adenosylmethionine prior to cyclization and aromatization. 
SCHEMElO 
Mc 0 Me 0 
0 0 SCoA 0 0 
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0 0 
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COCH3 OH Me COCH3 
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Isolation of Lichen Depsides 
The dried lichen thallus is crushed and extracted in a Soxhlet extractor with ether and 
then with acetone (if neccessary it is pre-extracted with hexane). Then the mixture of 
metabolites is separated by a combination of fractional crystallization, column 
chromatography, preparative layer chromatography or radial chromatography, depending 
on the quantity of material available. If a mixture of lichen acids present in a crude extract 
is difficult to separate using the above methods, then the mixture of acids can be benzylated 
with phenyldiazomethane or benzyl bromide and potassium hydrogen carbonate to give a 
mixture of the benzyl esters, which are much easier to separate chromatographically than 
the less soluble, more polar, free acids. The natural depsides (free acids) can be then 
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regenerated by hydrogenolysis of the benzyl esters using palladium on carbon as catalyst. 
A simple comparative t.l.c. of the initial extracts against the regenerated acids can be used 
to check for the formation of artefacts. 
Investigation and Structural Elucidation of Lichen Depsides 
Degradative hydrolysis, microhydrolysis, comparative thin layer chromatography 
and high performance liquid chromatography, 1 H and 13c n.m.r. spectroscopy, mass 
spectrometry and X-ray crystal analysis have all been used in the structural determination of 
lichen depsides. Ultimately the structure deduced by these methods can be confirmed by 
total synthesis and comparison of the synthetic and natural lichen substances. 
Degradative hydrolysis involves cleavage of the depside-ester linkage beween 
the A- and B-rings of the depside to give the· two component phenolic acids. Identification 
of the structure of these components can then be used to deduce the structure of the original 
depside. This classical method of structure determination 11 is still used, provided a pure 
sample of the depside can be isolated from the lichen. The depside-ester linkage can be 
cleaved by hydrolysis with concentrated sulfuric acid at 0° or by aqueous or methanolic 
potassium hydroxide at room temperature or higher. Sometimes it is preferable to esterify 
(diazomethane) the depside before hydrolysis with cold concentrated sulfuric acid, as the 
A- and B-ring products can then readily be separated and differentiated; the A-ring as a 
benzoic acid and the B-ring as a benzoate ester.25 Here one effects preferential cleavage of 
the more reactive depside-ester linkage over the alkyl (usually methyl) benzoate ester. 
Molho et a!. 26 used this method to confirm ttie structure of the depside 
4'-0-methylnorsekikaic acid (67), isolated from Ramalina luciae (Scheme 11). Hydrolysis 
of the new depside (67) in an acid medium gave two acids, which were identified by 
comparative t.l.c. as 2,4-dihydroxy-6-propylbenzoic acid (68) and 2,3-dihydroxy-
4-methoxy-6-propylbenzoic acid (69). Furthermore, when the known depside sekikaic 
acid (63) and (67) were methylated with diazomethane, they produced the same derivative 
(70), thus confirming the structure of the new depside. 
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Comparative thin layer chromatography (t.l.c.) and high performance 
liquid chromatography (h.p.l.c.) are used routinely today for the identification of 
lichen products. Samples of lichen metabolites, or an extract of whole lichens, plus a 
known standard are spotted on three thin layer silica gel plates and developed in each of the 
three independent standard solvent systems: (A) toluene:dioxane:acetic acid (180:45:5); 
(B*) hexane:methyl t-butyl ether:formic acid (140:72: 18); and (C) toluene:acetic acid 
(200:30).27 The plate is dried, sprayed with 10% sulfuric acid and dried at 100° for 10 
minutes. The colour of the spots, both in natural and ultraviolet light, and their relative 
positions compared with those of the control are used to identify each particular metabolite 
or to indicate the presence of any new, unknown, lichen compounds. 
H.p.l.c. is also of enormous value as metabolites with very similar Rp values on 
thin layer plates are often well separated by h.p.l.c. Moreover the peak intensity is 
approximately proportional to the amount of substance present, so that this affords a 
quantitative estimate of each lichen metabolite present in the extract. When using h.p.l.c. to 
confirm the identity of a natural metabolite, the natural sample and synthetic material are run 
consecutively for comparison. 
The technique of microhydrolysis, (a microscale hydrolysis of lichen depsides 
with sulfuric acid), followed by t.l.c. or h.p.1.c. analysis of the products was developed by 
Culberson.27 This method can be used when only small fragments of the lichens, and thus 
minute amounts of the extracts (ca. 0.1mg) containing mixtures of new metabolites, are 
available. 
C0--0 
McO OH 
(71) 
This technique was used to identify the new depsides, hyperlatolic acid (71) and 
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isohyperlatolic acid (30)28 , present in the lichen Fuse idea viridis. Microhydrolysis of 
isohyperlatolic acid (30) with concentrated sulfuric acid led to the formation of 
2-heptyl-6-hydroxy-4-methoxybenzoic acid (72) and 2,4-dihydroxy-6-pentylbenzoic acid 
(73) (Scheme 12). These acids were identified by comparison of their Rp values on t.l.c. 
and RT values on h.p.l.c. with those of the authentic acids. Hyperlatolic acid (71) was 
identified in a similar manner. Even so the tentative structures deduced in this manner 
need to be confirmed by unambiguous synthesis. 
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Tlvo dimensional thin layer chromatography is used for analyses of 
mixtures difficult to resolve by standard t.l.c. Here the correlation of the Rp values with 
chemical structures29 has enabled the tentative identification of many trace constituents in 
microextracts, among them new depsides. Thus the C3, c5 and C7 homologues in a 
particular series would show spots on 2 dimensional t.l.c with identical ultraviolet 
characteristics and colours after spraying, lying on a sloping straight line at nearly equal 
di . tances from each other. The c9 homologue would be expected to yield a spot on an 
extrapolation of this line. Such RF correlations were used to ten ta ti vely identify 
4-0-demethylglomelliferic acid (74) and 4-0- demethylloxodellic acid (75)30. 
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1 H n.m.r. spectra have been recorded routinely for all lichen depsides isolated in recent 
years and have provided invaluable assistance in determining the nature of the various 
substituents present. Thus Wilkins31 deduced the presence of an additional methoxy group 
in the new depside 2'-0-methylpseudocyphellarin A (76), by comparison of the 1 H n.m.r. 
spectrum with that of the known cogenor, pseudocyphellarin A (77). 
Me 
Me 
HO 
CHO 
C0-0 
OH ' Me 
(76) R= Me 
(77) R = H 
Me 
OR 
Me 
Another powerful structural probe is provided by l 3c n.m.r. spectroscopy, a 
technique which has been used n1ore widely in recent years.32 ·33 For example, the 
structures of the new depsides 3'-n1ethylevernic acid (34) and methyl 3'-methyllecanorate 
(78)34 were assigned using their l 3c spectra. 
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The mass spectra of lichen depsides also is used routinely in the determination of 
their structure. Even if no molecular ion is detected, a study of the daughter ions and the 
fragmentation pattern can lead to the identification of the substitution of the A-ring and, 
occasionally, the B-ring as well. Thus from their mass spectral fragments, Elix35 could 
differentiate beween perlatolic acid (79), dihydropicrolichenic acid (80) and 2'-0-methyl-
anziaic acid (81), three isomeric mono-0-methyl derivatives of anziaic acid. 
C0-0 
R20 OR1 C02H 
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X-ray crystal analysis has been used to determine the structures of several unusual, 
new lichen substances, e.g. leprolomin ( 19). 36 
Synthesis of Lichen Depsides 
A number of the above techniques have been used to deduce tentative structures of 
new lichen depsides, but such structures need to be confirmed. This is now normally done 
by total synthesis. In the normal convergent route to depsides, the A-ring precursor (a 
suitably substituted benzoic acid) and the 8-ring precursor (a substituted phenolic ester) are 
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prepared separately and then condensed in the penultimate stage. 
The obligatory key esterification step in the synthesis of depsides suffers from 
severe steric restrictions, as described by Ferguson,37 due to the presence of hydroxy or 
methoxy groups and the alkyl groups in positions ortho to the carboxy group of the A-ring. 
Further any potentially interfering hydroxy groups in either the A- or B-ring precursors 
need prior protection. 
Fischer and Fischer10 carried out the first synthesis of a depside, that of lecanoric 
acid (9) by the condensation of 2,4-diacetoxy-6-methylbenzoyl chloride (82) with orsellinic 
acid (15) in the presence of sodium hydroxide to give 2,4-di-O-acetoxylecanoric acid (83). 
Deacetylation of (83) then yielded lecanoric acid (9) (Scheme 13). This method suffered a 
loss in yield due to the competitive hydrolysis of the acid chloride during esterification and 
of the depside ester bond during deprotection. 
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In a more general synthesis of depsides (Scheme 14) Asahina et al. 11 protected all 
hydroxy groups by carboethoxylation, and condensed the appropriate acid chloride (84) 
with a phenolic aldehyde (85) (B-ring precursor). After oxidation of the product (86) to the 
corresponding acid (87) with potassium permanganate, mild hydrolytic deprotection 
afforded the depside (88). 
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Even though acid chlorides were relatively difficult to purify, they were used as the 
A-ring precursors in all these early methods. This meant that it was necessary to protect all 
the hydroxy groups so that during the subsequent hydrolytic removal of the protecting 
groups appreciable cleavage of the depside link occurred, considerably reducing the yield 
of the depside obtained. 
The use of a benzoic acid as the A-ring precursor was made possible by the 
discovery of the newer condensing agents trifluoroacetic anhydride,38 dicyclohexyl-
carbodiimide39 and N,N-carbonyldiimidazole.39 When a benzoic acid was used as the 
A-ring precursor, rather than the acid chloride, it was found to be unnecessary to protect 
the intramolecularly hydrogen bonded hydroxy groups, although the carboxy group of the 
B-ring still required protection. 
The standard synthetic procedure developed by Elix et a!.35A0.4I for the preparation 
of para- and meta-depsides has wide application. The synthetic strategy involves protection 
of the carboxy group on the B-ring precursor and the phenolic groups (except when 
intramolecularly hydrogen bonded) on both ring precursors by 0-benzylation. Then the 
appropriate benzoic acid (A-ring precursor) and benzyl benzoate (B-ring precursor) are 
dissolved in toluene and condensed at room temperature by treatment with trifluoroacetic 
anhydride. Subsequently the benzyl protecting groups are readily removed by catalytic 
hydrogenolysis at room temperature. The synthesis35 of the para-depside, anziaic acid 
(27), as depicted in Scheme 15 illustrates this method. 
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The Pu rposc of this Project 
The aim of the present project was to effect the total synthesis and structural 
confinnation of a number of depsides including: 
(i) a chemosyndrome of P-orcinol para-depsides isolated from an Erioderma sp. 
(ii) a chemosyndrome of fully substituted para-depsides isolated from the lichen 
Pseudocyphellaria pickeringii. 
(iii) a number of para-sphaerophorol depsides isolated from the lichens Fuscidea 
viridis, Di,neleana oriena and Sphaerophorus melanocarpus. 
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Chapter 2 
New P-Orcinol para-Depsides from an Erioderma Lichen 
Introduction 
During their revision of the lichen genus Erioderma, Arvidsson and J¢rgensen 
di scovered several specin1ens of a new Ecuadoran Erioderma species with unknown 
chen1istry and forwarded it to Elix in the hope that he might be able to deduce the 
chemical structure of the metabolites present. Using high-performance liquid 
chromatographic (h.p.l.c.) analysis of methanol extracts of these lichens, Elix and 
Jenkins detected the presence of seven unknown metabolites as well as two known 
depsides, methyl barbatate (89) and methyl 4-0-demethylbarbatate (90). The lichen 
samples were then extracted with acetone and the acetone extractives were separated by 
preparative layer chromatography, the various bands ultimately yielding nine natural 
esters. By examination of the 1 H n.m.r. and mass spectra of these compounds, Elix 
postulated that these metabolites probably constituted a chemosyndrome of P-orcinol 
para-depsides related to methyl 4-0-demethylbarbatate. The structural variations were 
due to the presence or absence of a 5-chloro substituent, the degree of C-methylation of 
the B-ring and the degree of 0-methylation of the three phenolic groups. The new 
depsides isolated were tentatively identified as methyl 5-chloro-4-0-demethylbarbatate 
(91 ),42 methyl eriodermate (92), methyl 2-0-methyleriodermate (93), methyl 
4-0 -methyleriodermate (94), methyl 2'-0-methyleiiodermate (95), and methyl 
2,2'-di-O-methyleriodermate (96). A mixed orcinol P-orcinol depside, which was at 
first thought to be methyl norobtusatate (97), but later shown to be methyl 
5-chloronorobtusatate (98), was also isolated. The unambiguous synthesis of each new 
compound was undertaken in order to confirm the assigned structures. Other possible 
co-metabolites considered were methyl 5-chloro-4-0-demethy 1-2,2 '-di-O-methy 1-
barbatate (99), methyl 2',4-di-0-methyleriodermate (100) and methyl 2,4-di-O-methyl-
eriodem1ate (101). These compounds were also synthesized and the lichen specimens 
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scanned for their presence. 
Synthesis of the Depsides (92) - (101) 
Total syn thesis is now the customary method for the structural confirmation of 
lichen depsides. The preparation of the A- and B-ring precursors was undertaken using 
the established methods for the total synthesis of depsides as described by Elix et 
al. 35 •4o.4 i (see Chapter 1, p 35). Firstly the phenolic hydroxy groups on the A-ring 
precursor were protected by 0-benzylation in order to maximize the yield in the 
condensation reaction. If such hydroxy groups were left unprotected the A-ring 
precursor would undergo self-condensation, and although this would be expected to 
occur at a slower rate than the depside formation, it would reduce the yield of the desired 
depside ester. Ethyl 2,4-dihydroxy-3,6-dimethylbenzoate (102) was used as the primary 
starting material for the preparation of all the A-ring precursors, as illustrated in Schemes 
17, 18, 20 and 21. 
SCHEME16 
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Ethyl 2,4-dihydroxy-3,6-dimethylbenzoate (102) was chlorinated by treatment 
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with 0.9 moles of sulfuryl chloride to form ethyl 3-chloro-4,6-dihydroxy-2,5-
dimethylbenzoate (103). The sulfuryl chloride behaves as a source of elemental chlorine 
and chlorinates phenols in the ortho and/or para positions at room temperature or below 
without the neccessity for a catalyst.43 The mechanism simply involves the polarization 
of the chlorine molecule by the attacking phenolic ring (nucleophile), which subsequently 
undergoes normal electrophilic substitution44 (Scheme 16). 
SCHEME17 
Me Me 
C02Et Cl C02Et 
S02Cl2 PhCH2Br 
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HO OH HO OH 
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(102) (103) 
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Cl C02Et Cl C02H 
KOH 
PhCH20 OCH2 Ph PhCH20 OCH2 Ph 
Me Me 
(104) (105) 
Both hydroxy groups of the chlorobenzoate (103) were protected by benzylation 
with benzyl bromide in the presence of potassium carbonate to give ethyl 
2,4-dibenzyloxy-5-chloro-3,6-dimethylbenzoate (1Q4). The ester (104) was 
subsequently hydrolysed with potassium hydroxide and after acidification yielded the 
required acid (105 ). 
A second A-ring precursor, 4-benzyloxy-3-chloro-6-methoxy-2,5-dimethylbenzoic 
acid (106) was prepared in the following manner. As the 2-hydroxy group of the ester 
(102) was intramolecularly hydrogen bonded to the ortho-ester group (Figure 1 ), it was 
less reactive towards alkylation than the non-bonded 4-hydroxy group. The presence of 
such hydrogen bonding was confirmed by the low field hydroxy resonance (o 12.0) in 
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the 1 H n.m.r. spectrum of (102). 
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Hence regioselective benzylation of (102) using 1.2 moles of benzyl bromide in 
the presence of potassium carbonate, afforded the 4-benzyloxy derivative (107). 
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Subsequent treatment of (107) with sulfuryl chloride yielded ethyl 4-benzyloxy-3-chloro-
6-hydroxy-2,5-dimethylbenzoate (108). The latter ester was then methylated by treatment 
with dimethyl sulfate in the presence of potassium carbonate to give the ester (109), 
which in turn was hydrolysed to give 4-benzyloxy-3-chloro-6-methoxy-2,5-dimethyl-
benzoic acid ( 106) (Scheme 18). 
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The synthesis of the third A-ring precursor, 2-benzyloxy-5-chloro-4-methoxy-
3,6-dimethylbenzoic acid (110) was more difficult (Scheme 20). As O-methylation45 
deactivates the aromatic ring towards chlorination, nuclear chlorination must be effected 
first. Hence ethyl 2,4-dihydroxy-3,6-dimethylbenzoate (102) was chlorinated to give the 
chloro-ester (103) as described previously. In compound (103) both of the hydroxy 
groups are involved in intramolecular hydrogen bonding. Although the hydrogen bond 
between the chlorine atom and the 4-hydroxy group was weaker than between the 
2-hydroxy and the ester group (as indicated by the downfield shift of the respective 
hydroxy protons in the 1 H n.m.r. spectrum; 8 6.19 cf. 8 11.90), the reactivity of the two 
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hydroxy groups was comparable under normal methylation conditions using dimethyl 
sulfate/potassium carbonate. Hence the following strategy was used. Both hydroxy 
groups of (103) were methylated by treatment with dimethyl sulfate in the presence of 
potassium carbonate to give ethyl 3-chloro-4,6-dimethoxy-2,5-dimethylbenzoate (111). 
Selective demethylation of (111) by treatment with boron trichloride yielded ethyl 
3-chloro-6-hydroxy-4-methoxy-2,5-dimethylbenzoate (112). The selectivity of such 
demethylation reactions with boron trichloride can be attributed to the formation of a 
cyclic complex (iii) involving both the methoxy and ester groups as shown in Scheme 19. 
Boron trichloride is ineffective in demethylating aryl methyl ethers lacking an 
ortho-carbonyl functionality. 
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The hydroxy group of (112) was then protected by benzylation and the resulting 
compound (113) hydrolysed to give the required acid, 2-benzyloxy-5-chloro-4-methoxy-
3,6-dimethylbenzoic acid (110). 
Hydrolysis of the above intermediate, ethyl 3-chloro-4,6-dimethoxy-2,5-
dimethylbenzoate (111) afforded the final A-ring precursor, 3-chloro-4,6-dimethoxy-2,5-
dimethylbenzoic acid (114) (Scheme 21). 
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One of the B-ring precursors, methyl orsellinate (115), was used as the primary 
starting material for the preparation of the second B-ring precursor, methyl 
2,4-dihydroxy-3,5,6-trimethylbenzoate (116), using methods previously described46 and 
summarized in Scheme 22. 
The third B-ring intermediate, methyl 2-methoxy-4-hydroxy-3,6-dimethylbenzoate 
(117) had been prepared previously.47 
Me 
HO OMc 
Me 
(117) 
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SC.HEl\1.E 22 
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The interconversion of the ester (116) into the final B-ring precursor, methyl 
4-hydroxy-2-methoxy-3,5,6-trimethylbenzoate (118) is outlined in Scheme 23. Here 
again the 2-hydroxy group was deactivated by intramolecular hydrogen bonding to the 
ortho-ester group, so regioselective alkylation will occur at the 4-position. Thus selective 
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benzylation of methyl 2,4-dihydroxy-3,5,6-trimethylbenzoate (116) with 1.2 moles of 
benzyl bromide gave the 4-0-benzyl compound (119), and subsequent methylation 
afforded methyl 4-benzyloxy-2-methoxy-3,5,6-trimethylbenzoate (120). Hydrogenolysis 
of the latter ester (120) yielded the required phenol, methyl 4-hydroxy-2-methoxy-3,5,6-
trimethylbenzoate (118). 
SCHE1\1E23 
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The condensation of the A-ring precursors (105), (106), (110) and (114) with the 
appropriate B-ring precursors ( 115), ( 116), ( 117) and ( 118) by treatment with 
trifluoroacetic anhydride led to the depside esters (121), (122), (123 ), (124), (125), 
(126), (127), (128) and (101) (Scheme 24). Methyl 4-0-benzylnorobtusatate (129) was 
prepared in a similar way by condensation of 4-benzyloxy-2-hydroxy-3 ,6-methylbenzoic 
acid (130) with the B-ring precursor (115). The A-ring precursor (130) was obtained by 
hydrolysis of a previous intermediate ethyl 4-benzyloxy-2-hydroxy-3,6-methylbenzoate 
( 107). 
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Trifluoroacetic anhydride is often used as the reagent in the synthesi of depsides 
and the two most probable (alternative) mechanisms for such esterification reactions are 
shown in Schemes 25 and 26. The former4 8.49 involves the formation of the protonated 
mixed anhydride (v), while the formation of the acylium ion (vii) is postulated in the 
latter.49,50 
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SCHEME26 
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Hydrogenolysis of the esters (121) - (129) by treatment with hydrogen in the 
presence of a palladium on carbon catalyst yielded the depsides (92) - (100). 
1 H n.m.r. Spectra of Depsides (92) - (96) and (98). 
The 1 H n.m.r. spectra of the depside esters (121), (122), (123), (124), (125) and 
(126) and the depsides (92), (93), (94), (95), (96) and (98) exhibited the expected 
resonances. A comparison of the spectra of (92), (94) and (95), each of which has a 
2-hydroxy group, with the corresponding 2-benzyloxy con1pounds (121), (123) and 
(124), showed that the 3-methyl group shifted upfield ca. 0.25 ppm in the latter. Thus on 
removal of the benzyloxy group the geometry of these compounds must change 
markedly. Most probably the 2-benzyloxy group is too bulky to enable both A- and 
B-rings to be coplanar (Figure 2a) whereas this is facilitated when the 2-hydroxy group is 
H-bonded to the carboxy group (Figure 2b). 
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Mass Spectra of the Depsides (92) - (96) and (98). 
Mass spectrometry was also used to characterise the new depsides (92), (93), 
(94), (95), (96) and (98). Normally the positive ion spectra (electron impact) of 
depsides do not exhibit a molecular ion peak. However, -as these depsides (92) - (96) and 
(98) were all esters rather than the more common free carboxylic acids, each showed a 
small molecular ion peak. The major mass spectral fragmentation pathways observed 
(Scheme 27) were comparable with those observed previously for analogous depsides.41 
The main fragmentation pathway appeared to be route z involving acyl-oxygen cleavage 
of the depside ester bond. Indeed the base peaks at mlz 213 for depsides (93), (94) and 
(96) and at ml z l 99 for depside (92) are all daughter ions (I) due to such ring-A 
fragments, as is the peak at mlz 199 for depside (95). The A-ring origin of these ions 
Mc 
Cl co-f-o 
HO OR1 Mc 
Mc 
R1 R2 
(92) H H 
(93) Mc H 
(95) H Me 
(96) Mc Mc 
Me 0 
Cl \\ uo 
A jH 
HO O Me 
Mc 
(92) R2=H 
(95) R2=Me 
Me 
0 Cl c? 
HO 0 
Mc 
(II) 
HO 
Me 
SCHEME27 
Mc l~ 
OR2 
route z 
C02Mc 
Mc 
Me OJ~ 
C02Me 
Me 
+ 
HO 
+ 
Me 
R2=H 
-MeOH 
Me + 
0 
0 
Mc 
Mc 
....--::0+ 
Cl c~ 
HO OR1 
Mc 
(I) 
Me + 
OR2 
C02Me 
Me 
(Ill) 
R2=M~ 
-OMe 
HO 
Me 
Me 
Me 
(IV) 
OMe 
c~ + 
~o 
52 
53 
was confirmed by the appearance of accompanying isotopic ions at mlz 215 and 201 
respectively (due to the 37 Cl isotope). Although depsides (93) and (96) appear to 
fragment exclusively by route z, the depsides (92), (94) and (95) also fragment by 
depside ester cleavage with hydrogen transfer (i.e. route x) as shown by the daughter 
ions (II) at mlz 198 or 212 arising from ring-A and daughter ions (III) at mlz 210 or 224 
arising from ring-B. The fragment ion (IV) giving rise to the base peak at mlz 193 in the 
spectrum of the depside (95) appears to be due to loss of an 0-methyl group from the 
B-ring fragmentation. A similar loss appears to occur from the analogous B-ring 
fragment in the spectrum of the depside (96). 
Comparison of Natural and Synthetic Material 
Comparative h.p.l.c. and t.l.c. of the synthetic depsides (92), (93), (94), (95), 
(96) and (98) with extracts of the Erioderma sp. established that these depsides were 
identical with the corresponding natural esters in the lichens. This was further confirmed 
by comparison of the 1 H n.m.r. and mass spectra of the synthetic and isolated natural 
material. 
Thus the synthesis of methyl eriodermate (92), methyl 2-0-methyleriodermate 
(93), methyl 4-0-methyleriodermate (94), methyl 2'-0-methyleriodermate (95), methyl 
2,2'-di-O-methyleriodermate ( 96), and methyl 5-chloronorobtusatate (98) confirmed the 
structures of these natural products. 
The synthesis of methyl 5-chloro-4-0-demethyl-2,2'-di-O-methyl-barbatate (99), 
methyl 2',4-di-0-methyleriodermate (100) and methyl 2,4-di-O-methyleriodermate (101) 
established that these depsides were not present in this Erioderma species. 
54 
Figure 3. H.p.1.c. trace of acetone extract of Erioderma sp. 
G 
F 
H I 
Peak Compound Area 
A unknown 4.64 4.0% 
B methyl 2,2'-cli-O-methyleriodermate (96) 4.91 4.1% 
C unknown 5.33 8.0% 
D methyl 2-0-methyleriodermate (93) 5.65 8.0% 
E methyl 4-0-demethylbarbatate (90) 5.91 8.4% 
F methyl eriodermate (92) 6.76 11.3% 
G methyl 5-chloro-4-0-demethylbarbatate (91) 7.31 42.7% 
H unknown 8.34 2.1% 
I methyl 4-0-methyleriodermate (94) 9.50 4.1% 
or methyl barbatate (89) 
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Biosynthetic Implications 
Fully substituted depsides are rather rare in nature and indeed, before the isolation of 
the depsides (92)-(96), the only known examples were phenarctin (131 ), 
pseudocyphellarin A (77) and pseudocyphellarin B (132). The high degree of 
methylation and apparent lack of selectivity in the site of methylation observed in the 
depsides (92) - (96) led to the conclusion that a very powerful methylating enzyme was 
present in this lichen. Furthermore the co-occurrence of methyl 5-chloronorobtusatate 
(98), methyl 5-chloro-4-0-demethylbarbatate (91) and methyl eriodermate (92) and 
cogenors (93) - (96) probably indicates that this enzyme effects both C-methylation prior 
to aromatization as well as 0-methylation after aromatization. The fact that 0-methylation 
proceeds with little or no site selectivity (occurring at the 2'-0H, 2-0H or 4-0H groups) 
or functional selectivity (occurring at C02H or OH) reaffirms this conclusion. 
Me Me 
C0-0 OH 
HO OH Me C02Me 
R1 Me 
R1 R2 
(131) CHO CHO 
(77) CHO Me 
(132) CH20H Me 
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Experimental 
General 
1 H n.m.r. spectra were recorded at 60 MHz on a Varian EM360 spectrometer, and 
chen1ical shifts were measured on the o scale relative to tetramethylsilane as internal 
standard. Low resolution mass spectra were carried out by Mr. M. Chapman under the 
direction of Dr. J. K. McLeod using a Y6 Micromass 7070F mass spectrometer at 70 eV. 
Microanalyses were carried out by the A.N. U. Microanalytical Laboratory under the 
direction of Mrs. R. Chao. Melting points were determined on a calibrated Reichert hot 
bench unless they were less than 50° when a Gallenkamp melting point apparatus was 
used. All melting points were uncorrected. 
For h.p.1.c. analysis, fragments of the thallus were extracted with warm methanol 
(ca. 35°) and the cooled extracts were filtered (0.45 µm pore size Durapore type HVLP) 
Small volumes were chromatographed on a Perkin-Elmer C-18HS-5 h.p.1.c. column with 
water-methanol (10:90) containing a trace of orthophosphoric acid (80 µ1/400 ml) at 0.6 
ml/min (1400 psi). The compounds were detected at 254 nm, and peaks were identified 
by comparison of retention times with those of authentic known samples. 
Light petroleum refers to the fraction boiling between 60 and 90°, and was 
redistilled. Anhydrous toluene was dried over SA type molecular sieve. Merck silica gel 
(70-230 mesh) was used in column chromatography, preparative layer chromatographic 
plates (100 x 20 x 0.1 cm were coated with silica gel (Merck PF254)' while silica gel 
(Merck PF254+ 366) was used to coat the radial chromatographic plates used on a 
Harrison Research Chromatotron model 7924T. Compounds were detected by exposure 
to short wavelength ultraviolet light. For column chromatography, the crude product was 
preadsorbed by mixing with dry silica gel before adding light petroleum. The solvent 
was then evaporated and the resulting solid added to the head of the silica gel column. 
Extraction of Erioderma sp. 
This experiment was performed by Dr. J. A. Elix. 
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The lichen material was collected in Ecuador: Loja, 6 km south of Saraguru, 3000 
m, L. Arvidsson and D. Nilson 2134 (GB). The dried lichen thallus (0.8 g) was 
extracted with four portions of boiling acetone (10 ml), the solution concentrated and 
applied to two silica gel plates (20 by 20 by 0.1 cm) and eluted with 
chlorofonn/toluene/acetone 10:8:1. Seven major bands developed. These were removed 
individually and extracted with boiling ethyl acetate and chloroform. The solutions so 
obtained were evaporated under reduced pressure and the residues crystallized from an 
appropriate solvent. The fastest moving band yielded methyl 4-0-methyleriodermate (94) 
(1.4 mg, 0.2% ); the second band contained methyl 5-chloro-4-0-demethylbarbate (91) 
( 1.6 mg, 0.2 % ); the third band, methyl eriodermate (92) (8 mg, 1 % ); the fourth band, 
methyl 2'-0-methyleriodermate (95) (1.8 mg, 0.2o/o ); the fifth band, methyl 2-0-
methyleriodermate (93) (4 mg, 0.5%); the sixth band, methyl 2,2'-di-O -
methyleriodermate (96) (1.4 mg, 0.2%) and the seventh band, methyl 4-0-demethyl-
barbatate (90) (1.3 mg, 0.2%). Methyl 5-chloronorobtusatate (98) was isolated from an 
eighth band (overlapping but slightly slower than band seven). The identity of these 
compounds was confirmed by comparison ( 1 H n.m.r., m.s., t.l.c. and h.p.l.c.) with the 
compounds prepared below by unambiguous synthesis. 
Synthesis 
Ethyl 3-C hloro-4 ,6-dihydroxy-2 ,5-dimethylbenzoate ( 103) 
Ethyl 2,4-dihydroxy-3,6-dimethylbenzoate ( 102) (5.25 g, 25 mmol) was 
dissolved in anhydrous ether (200 ml) and stirred with sulfuryl chloride (2.5 ml, 22 
mmol) in anhydrous ether (75 ml) at room temperatureJor 3 h. The yellow reaction 
mixture was poured into ice-water, the water layer was extracted with ether, and the 
combined ether layers were washed with water, with saturated sodium hydrogen 
carbonate, with saturated brine and dried (MgS04). The crude product (5.6 g, 92%) 
crystallized from dichloromethane as colourless long oblong prisms of ethyl 
3 -chloro -4,6-dihydroxy-2,5-dimethylbenzoate, (103) m.p. 122.5° (Found: C, 54.3; H 
5.5; Cl 14.3. C11H13Cl04 requires C, 54.0; H, 5.4; Cl, 14.5o/o). 1H n.m.r. (CDCI3) 
o 1.40, t, J 7 Hz, OCH2CH3; 2.17, 2.61, both s, ArCH3 x 2; 4.55, q, J 7.5 Hz, 
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OCH2CH3; 6.19, 11.90, both s, OH x 2. Mass spectrum mlz 244 (M, 39%), 198 
(100). 
Ethyl 2 ,4-Dibenzyloxy-5-chloro-3 ,6-dimethylbenzoate (104) 
Ethyl 3-chloro-4,6-dihydroxy-2,5-dimethylbenzoate (103) (5.74 g, 23.5 mmol), 
anyhdrous potassium carbonate (18.42 g) and benzyl bromide (8.5 g, 5.9 ml) were 
stirred and heated under reflux in acetone (160 ml) for 26 h. The mixture was poured 
into cold, dilute hydrochloric acid, extracted with ether, and the ethereal extract was 
washed with 4% sodium hydroxide solution, with water and with saturated brine and 
dried (MgS04). Most of the benzyl bromide was removed on the vacuum pump before 
passing the residual oil through a column of silica gel using 5o/o ethyl acetate-light 
petroleum as eluant. The desired product was contained in both the second (4.10 g) and 
third fractions (4.92 g) collected. The second fraction was further purified (to remove 
benzyl bromide) by radial chromatography (Si02) using 5% ethyl acetate-light petroleum 
as eluant. Ethyl 2,4-dibenzyloxy-5-chloro-3,6-dimethylbenzoate (104) (8.74 g, 87.7%) 
was obtained as a colourless oil (Found: C, 70.7; H, 6.3; Cl, 8.2. C25H25Cl04 
requires C, 70.7; H, 5.9; Cl, 8.3%). 1 H n.m.r. (CDCl3) 8 1.29, t, J 7 Hz, 
OCH2CH3; 2.17, 2.37, both s, ArCH3 x 2; 4.35, q, J 1 Hz, OCH2CH3; 4.92, 4.97, 
both s, OCH2Ar x 2; 7.48, bs, C6H5 x 2. Mass spectrum: mlz 424 (M, 0.9%), 91 
( 100). 
2 ,4-Dibenzyloxy-5-chloro-3 ,6-dimethylbenzoic Acid ( 105) 
A solution of ethyl 2,4 dibenzyloxy-5-chloro-3,6-d_imethylbenzoate (104) (5.39 g, 
12.7 mmol) in dimethyl sulfoxide (62 ml) and potassium hydroxide (2.8 g) in water 
(12.5 ml) was stirred and heated at 98° for 4 h. After standing for 14 h the mixture was 
diluted with water and washed with ether. The basic aqueous layer was poured into cold, 
dilute hydrochloric acid, extracted with ether and the ethereal extract was washed with 
water, with saturated brine and dried (MgS04). On removal of solvent the residue was 
crystallized from cyclohexane to give 2,4-dibenzyloxy-5-chloro-3 ,6-dirnethylbenzoic acid 
(105) (4.34 g, 86%) as colourless hair-like needles, rn.p. 152° (changes phase or softens 
59 
ca. 140°) (Found: C, 69.3; H, 5.4; Cl, 9.1. C23H21 CI04 requires C, 69.6; H, 5.3; 
Cl, 8.9%). 1H n.m.r. (CDCI3) o 2.18, 2.46, both s, ArCH3 x 2; 4.90, 4.94, both s, 
OCH2 x 2; 7.38, 7.42, both s, C6H5. Mass spectrum: mlz 396 (M, 0.9%), 91 (100). 
Ethyl 4-Benzyloxy-3-chloro-6-hydroxy-2 ,5-dimethylbenzoate (108) 
Sulfuryl chloride (4 ml) dissolved in anhydrous ether (75 ml) was added dropwise 
to a solution of ethyl 4-benzyloxy-2-hydroxy-3,6- dimethylbenzoate (107) (11.44 g, 38.1 
mmol) dissolved in anhydrous ether (200 ml) over 30 min. and the mixture stirred for a 
further 5 h. Then the reaction mixture was poured into ice-water and the aqueous layer 
extracted with ether. The combined ether extract was washed with water, with sodium 
hydrogen carbonate, with saturated brine and dried (MgSO~. On removal of the solvent 
the crude product (12.6 g, 99%) was obtained as a yellow oil. A portion (8.6g) was 
purified by passing through a column of silica gel using 2.5% ethyl acetate-light 
petroleum as eluant. The first fraction yielded pure ethyl 4-benzyloxy-3-chloro-
6-hydroxy-2 ,5-dimethylbenzoate (108) (8.2 g, 94%) as a pale yellow oil which 
crystallized on standing to form colourless prisms, m.p. 48° (Found: C, 64.4; H, 5.7; 
Cl, 10.7. C13H19Cl04 requires C, 64.6; H, 5.7; Cl, 10.6%). 1H n.m.r. (CDCl3) o 
1.40, t, J 7 Hz, OCH2CH3; 2.16, 2.64, both s, ArCH3 x 2; 4.44, q, J 7 Hz, 
OCH2CH3; 4.95, s, OCH2Ar; 7.49, bs, C6H5; 11.62, s, OH. Mass spectrum: mlz 
334 (M, 12%), 91(100). 
Ethyl 4-Benzyloxy-3-chloro-6-methoxy-2 ,5-dimethylbenzoate (109) 
Ethyl 4-benzyloxy-3-chloro-6-hydroxy-2,5-dimethylbenzoate ( 108) ( 4.0 g, 11.9 
mmol), dimethyl sulfate (1.3 ml, 13.5 mmol), anhydrous potassium carbonate (5 g) and 
anhydrous acetone (100 ml) were stirred and heated under reflux for 20 h. The mixture 
was poured into cold, dilute hydrochloric acid and extracted with ether. The ethereal 
extract was washed with water, with saturated ammonium chloride solution and dried 
(MgS04). The crude product (4.1 g) obtained on removal of the solvent was passed 
through a short silica gel column using 5% ethyl acetate-light petroleum as eluant. The 
first fraction obtained was purified further by radial chromatography (Si02) and 
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combined with the pure second fraction to give ethyl 4-benzy/oxy-3-chloro-6-methoxy-
2,5-dimethy/benzoate (109) (3.6 g, 86%) as a colourless oil (Found: C, 65.7; H, 6.2; 
Cl, 10.3. C19H21 Cl04 requires C, 65.4; H, 6.1; Cl, 10.2%). lH n.m.r. (CDC13) 8 
1.39, t, I 7 Hz, OCH2CH3; 2.20, 2.37, both s, ArCH3 x 2; 3.80, s, OCH3; 4.48, q, 
I 7 Hz, OCH2CH3; 4.98, s, OCH2Ar; 7 .50, bs, C6H5. Mass spectrum: mlz 348 (M, 
34% ), 91 (100). 
4-Benzyloxy-3-chloro-6-methoxy-2 ,5-dimethylbenzoic Acid ( 106) 
A mixture of ethyl 4-benzyloxy-3-chloro-6-methoxy-2,5-dimethylbenzoate (109) 
(3.2 g, 9 mmol) dissolved in dimethyl sulfoxide (52 ml) and potassium hydroxide (2 g) 
dissolved in water (9 ml) was stirred and heated at 90-95° for 4 h, then diluted with water 
and washed with ether to remove any unreacted starting material. The basic aqueous 
layer was poured into cold, dilute hydrochloric acid, extracted with ether and the ethereal 
extract washed with water, with saturated brine and dried (MgS04). After removal of the 
solvent the residue was crystallized from cyclohexane to give 4-benzyloxy-3-chloro-6-
methoxy-2 ,5-dimethylbenzoic acid ( 106) (2.48 g, 85%) as almost colourless crystals, 
m.p. 129°. On crystallization from dichloromethane, (106) was obtained as colourless 
rectangular prisms, m.p. 129° (Found: C, 63.6; H, 5.5; Cl, 11.1. C17 H 17ClO 4 
requires C, 63.7; H, 5.3; Cl, 11.1 %). 1 H n.m.r. (CDCl3) 8 2.20, 2.48, both s, 
ArCH3 x 2; 3.86, s, OCH3; 5.00, s, OCH2; 7.52, bs, C6H5; 10.12, vbs, C02H. 
Mass spectrum: mlz 320 (M, 1.6%), 91(100). 
Ethyl 3-Chloro-4,6-dimethoxy-2,5-dimethylbenzoate (111) 
A solution of ethyl 3-chloro-4,6-dihydroxy-2,5-dimethylbenzoate (103) (5.6 g, 23 
mmol) in anhydrous acetone (100 ml) was stirred and heated under reflux with dimethyl 
sulfate (4.9 ml, 52 mmol) and anhydrous potassium carbonate (19.6 g) for 21 h. The 
reaction mixture was poured into cold, dilute hydrochloric acid, extracted with ether and 
the ethereal extract washed with 5% sodium hydroxide solution, with water, with 
saturated brine and dried (MgS04). After removal of the solvent, the residue was passed 
through a short column of silica gel using 5% ethyl acetate-light petroleum as eluant to 
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give ethyl 3-chloro-4,6-dimethoxy-2S-dimethylbenzoate (111) (6.1 g, 98%) as an almost 
colourless oil. A small sample was purified further by radial chromatography (Si02) 
with 2.5% ethyl acetate-light petroleum as eluant to give (111) as a colourless oil (Found: 
C, 57.5; H, 6.3; Cl, 13.1. C13H1 7Cl04 requires C, 57.3; H, 6.3; Cl, 13.0%). lH 
n.m.r. (CDCl3) 8 1.37, t, J 1 Hz, OCH2CH3; 2.21, 2.28, both s, ArCH3 x 2; 3.76, 
3.79, both s, OCH3 x 2; 4.44, q, J 1 Hz, OCH2CH3. Mass spectrum: mlz 272 
(M,46%), 227 (100). 
Ethyl 3-C hloro-6-hydroxy-4-methoxy-2 ,5-dimethylbenzoate ( 112) 
Ethyl 3-chloro-4,6-dimethoxy-2,5-dimethylbenzoate (111) (1.72 g, 6.3 mmol) 
was dissolved in anhydrous dichloromethane (100 ml) and cooled to -78°. A solution of 
ooron trichloride (5.5g) in dichloromethane (60 ml) was cooled to 0° and added dropwise 
to the above solution over 35 min. with stirring. After stirring for a further 1 hat - 78°, 
the mixture was allowed to wann to room temperature and stirring continued for a further 
4 h. The mixture was then poured into ice-water, extracted with chloroform and the 
organic layer washed with saturated sodium hydrogen carbonate solution, with water, 
with saturated brine and dried (MgS04). The crude product was purified by radial 
chromatography (Si02) using 2.5% ethyl acetate-light petroleum as eluant. Ethyl 
3-chloro-6-hydroxy-4-methoxy-2,5-dimethylbenzoate (112) (1.08 g, 66%) crystallized 
from dichloromethane-light petroleum as colourless needles, m.p. 58° (Found: C, 55.8; 
H, 6.0; Cl, 13.4. C12H15Cl04 requires C, 55.7; H, 5.8; Cl, 13.7%). 1H n.m.r. 
(CDCl3) 8 1.40, t, J 1 Hz, OCH2CH3; 2.18, 2.58, both s, ArCH3 x 2; 3.76, s, 
OCH3; 4.43, q, J 1 Hz, OCH2CH3; 11.60, s, OH. Mass spectrum: mlz 258 (M, 
43%), 212 (100). 
Ethyl 2-Benzyloxy-5-chloro -4-methoxy-3,6-dimethylbenzoate (113) 
Ethyl 3-chloro-6-hydroxy-4-methoxy-2,5-dimethylbenzoate ( 112) ( 4.0 g, 15.5 
mmol), benzyl bromide (2.81 g, 1.95 ml), anhydrous potassium carbonate (6.1 g) were 
stirred and heated under reflux in anydrous acetone (100 ml) for 22 h. After cooling, the 
mixture was poured into cold, dilute hydrochloric acid and extracted with ether. The 
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ethereal extract was washed with water, with saturated brine and dried (MgS04). After 
removal of solvent, the residue was purified by consecutive column and radial 
chromatography (Si02) using 2.5% ethyl acetate-light petroleum as eluant to give ethyl 
2-benzy/oxy-5-ch/oro-4-methoxy-3 ,6-dimethy/benzoate (113) ( 4.75g, 88%) as a 
colourless oil (Found: C, 65.6; H, 5.9; Cl, 10.2. C19H21 Cl04 requires C, 65.4; H, 
6.1; Cl, 10.2%). l H n.m.r. (CDCl3) 8 1.29, t, J 7 Hz, OCH2CH3; 2.23, 2.32, both 
s, ArCH3 x 2; 3.81, s, OCH3; 4.35, q, J 7 Hz, OCH2CH3; 4.92, s, OCH2Ar; 7 .43, 
s, C6H5. Mass spectrum: mlz 348 (M, 16%), 91(100). 
2-Benzyloxy-5-chloro-4-methoxy-3 ,6-dimethylbenzoic Acid (110) 
A mixture of ethyl 2-benzyloxy-5-chloro-4-methoxy-3,6-dimethylbenzoate (113) 
(2.0 g, 0.57 mmol) dissolved in dimethyl sulfoxide (33 ml) and potassium hydroxide in 
water (5.7 ml) was stirred and heated at 90~100° for 4.5 h. The mixture was diluted with 
water and washed with ether. The basic aqueous layer was poured into cold, dilute 
hydrochloric acid and extracted with ether. The ethereal extract was washed with water, 
with saturated brine and dried (MgS04). The colourless solid (2.0 g) obtained on 
removal of solvent crystallized from dichloromethane-light petroleum to give 
2-benzy/oxy-5-chloro-4-methoxy-3 ,6-dimethy/benzoic acid (110) (1.47 g, 80%) as 
colourless prisms, m.p. 156° (Found: C, 63.7; H, 5.6; Cl, 11.3. C17 H 17ClO 4 
requires C, 63.7; H, 5.3; Cl, 11.1%). lH n.m.r. (CDC13) 8 2.24, 2.41, both s, 
ArCH3 x 2; 3.85, s, OCH3; 4.95, s, OCH2; 7.42, bs, C6H5; 9,90, bs, C02H. Mass 
spectrum: mlz 320 (M, 26o/o), 91(100). 
Methyl 4-Benzyloxy-2-hydroxy-3 ,5 ,6-trimethylbenzoate ( 119) 
Methyl 2,4-dihydroxy-3,5,6-trimethylbenzoate (116) (2.10 g, 10 mmol), benzyl 
bromide (1.82 g, 1.26 ml), and anhydrous potassium carbonate (3.94 g) were stirred 
and heated under reflux in anhydrous acetone (120 ml) for 20 h. The mixture was poured 
into cold, dilute hydrochloric acid, extracted with ether and the ethereal extract washed 
with water, with saturated brine and dried (MgS04). The product was purified on a silica 
gel column using 5% ethyl acetate-I" ght petroleum as eluant, and then crystallized from 
.... 
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ethyl acetate-light petroleum to give methyl 4-benzyloxy-2-hydroxy-3,5,6-trimethyl-
benzoate (119) (2.2 g, 73%) as colourless prisms, m.p. 58° (Found: C, 71.8; H, 6.7. 
C1gH2o04 requires C, 72.0; H, 6.7%). 1 H n.m.r. (CDC13) 8 2.20 (6H), 2.42, both 
s, ArCH3 x 3; 3.96, s, OCH3; 4.78, s, OCH2; 7.46, s, c6H5; 11.23, s, OH. Mass 
spectrum: mlz 301 (M, 23%), 91(100). 
Methyl 4-Benzyloxy-2-methoxy-3,5,6-trimethylbenzoate (120) 
Methyl 4-benzyloxy-2-hydroxy-3,5,6-trimethylbenzoate (119) (2.53 g, 8.4 
mmol), dimethyl sulfate 2.60 g, 1.79 ml), and anhydrous potassium carbonate (6.8 g) 
were stirred and heated under reflux in anhydrous acetone (200 ml) for 23.5 h. The 
mixture was acidified, extracted and washed in the usual manner and purified by radial 
chromatography (Si02) using 2.5% ethyl acetate-light petroleum as eluant. Methyl 
4-benzyloxy-2-methoxy-3,5,6-trimethylbenzoate (120) (1.9 g, 73%) was obtained as a 
colourless oil, which partly crystallized as tiny colourless prisms on standing at room 
temperature (Found: C, 72.3; H, 7.5. C19H2204 requires C, 72.6; H, 7.1 %). 1H 
n.m.r. (CDCI3) 8 2.17 (9H), s, CH3 x 3; 3.76, s, OCH3; 3.94, s, C02CH3; 4.77, 
s, OCH2; 7.47, s, C6H5. Mass spectrum: mlz 314 (M, 16%), 91(100). 
Methyl 4-Hydroxy-2-methoxy-3 ,5,6-trimethylbenzoate ( 118) 
Methyl 4-benzyloxy-2-methoxy-3,5,6-trimethylbenzoate (120) (2.6 g) was stirred 
in ethyl acetate ( 40 ml) containing 10% palladium-on-carbon ( 130 mg) at room 
temperature in a hydrogen atmosphere for 23 h. Further catalyst ( 110 mg) and hydrogen 
was added after 7 h. The catalyst was removed by filtrati9n and the solvent evaporated. 
The product was purified by radial chromatography (Si02) using 20% ethyl acetate-light 
petroleum as eluant. Methyl 4-hydroxy-2-methoxy-3,5,6-trimethylbenzoate (118) (1.70 
g, 92o/o) was obtained as a colourless solid which crystallized from dichloromethane-light 
petroleum as colourless, narrow prisms, m.p. 82° (Found: C, 64.4; H, 7 .0. 
C12H1604 requires C, 64.3; H, 7.2%). 1H n.m.r. (CDCI3) 8 2.10, 2.13 (6H), both 
s, ArCH3 x 3; 3.73, s, OCH3; 3.90, s, C02CH3; 4.95, s, OH. Mass spectrum: mlz 
224 (M, 29%), 193(100). 
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3-Chloro-4,6-dimethoxy-2,5-dimethylbenzoic Acid (114) 
A solution of ethyl 3-chloro-4,6-dimethoxy-2,5-dimethylbenzoate ( 111) (1.26 g, 
4.62 mmol) in dimethyl sulfoxide (27 ml) and potassium hydroxide ( 1.0 g) in water ( 4.6 
ml) was stirred and heated at 90-100° for 4 h. The mixture was diluted with water and 
washed with ether to remove any starting material. The basic aqueous layer was poured 
into cold, dilute hydrochloric acid, extracted with ether, and the ethereal extract was 
washed with water, with saturated brine and dried (Mg SO 4). On removal of the solvent, 
the residue was crystallized from dichloromethane-light petroleum to give 
3-chloro-4,6-dimethoxy-2,5-dimethylbenzoic acid (114) (1.06 g, 94%) as colourless 
prisms, m.p. 94° (Found: C, 54.2; H, 5.4; Cl, 14.5. C11 H 13Cl04 requires C, 54 .. 0; 
H, 5.4; Cl, 14.5%). 1 H n.m.r. (CDC13) 8 2.22, 2.40, both s, ArCH3 x 2; 3.81, s, 
OCH3 x 2; 11.16, s, C02H. Mass spectrum: mlz 244 (M, 95.5%), 246 (32o/o), 226 
(100). 
Synthesis of Depsides - General Procedure 
The appropriate carboxylic acid (1 mmol) and methyl ester (1 mmol) were 
dissolved in a solution of anhydrous toluene ( 4 ml) and trifluoroacetic anhydride (1 ml) 
and stood at room temperature for 3-22 h (until nearly all the starting material had reacted, 
as shown by t.l.c.). For the preparation of (33) and (32) it was necessary to employ 
additional trifluoroacetic anhydride (2-3 ml total) and to stir the mixture for 5 h at room 
temperature, due to the limited solubility of the reactants. After removal of the solvent 
under reduced pressure, the residue was purified by radial chromatography (Si02), 
Elution with 2.5-5-10% ethyl acetate-light petroleum developed the major depside ester 
band ahead of any unwanted side products or the unreacted starting material. After 
removal of the solvent, the depside ester was recrystallized from dichloromethane-light 
petroleum. The depside ester was then dissolved in ethyl acetate containing a suspension 
of 10% palladium-on-carbon and stirred under a hydrogen atn1osphere for 1-3 h. The 
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catalyst was filtered, the solvent evaporated and the depside purified in the same manner 
as the depside ester-i.e. by radial chromatography (Si02) using 5-10% ethyl acetate-light 
petroleum as eluant, followed by crystallization from dichloromethane-light petroleum. 
Standard RF values were determined in three independent t.l.c. solvent systems: (A) 
toluene:dioxane:acetic acid (180:45:5);51 (B*) hexane:methyl t-butyl ether:formic acid 
(140:72: 18);52 and (C) toluene:acetic acid (200:30).53 
Methyl 2-0-Methyleriodermate (93) 
Methyl 4-0-benzyl-2-0-methyleriodermate (122) (43%) crystallized in colourless 
microcrystals, m.p. 120° (changes form at 108°) Found: C, 65.7; H, 5.7; Cl, 7 .1. 
C23H29Cl07 requires C, 65.6; H, 5.7; Cl, 6.9%). 1H n.m.r. (CDCl3) 8 2.21 (9H), 
2.47, 2.55, each s, ArCH3 x 5; 3.80, s, OCH3; 3.98, s, C02CH3; 4.98, s, OCH2; 
7 .45, bs, C6H5; 11.21, s, OH. Mass spectrum: mlz 512 (M, 0.1 % ), 303 ( 100). 
Methyl-2-0-methyleriodermate (93) (85%) crystallized in colourless prisms, m.p. 
167° (Found: C, 59.8; H, 5.5; Cl, 8.5. C21 H23Cl07 requires C, 59.7; H, 5.5; Cl, 
8.4%). 1 H n.m.r. (CDCl3) 8 2.20 (6H), 2.25, 2.48 (6H) each s, ArCH3 x 5; 3.83, s, 
OCH3; 3.98, s, C02CH3; 5.98, 11.20, both s, OH x 2. Mass spectrum: mlz 422 
(M, 0.2%), 215 (32), 214 (12), 213 (100), 178 (7), 170 (5), 150 (6). Standard RF 
values: RF(A) 69; Rp(B*) 62; RF(C) 68. This compound proved identical ( 1 H 
n.m.r., m.s., t.l.c., h.p.l.c.) with a minor metabolite of the Erioderma sp. 
Methyl 2,2'-Di-O-methyleriodermate (96) 
Methyl 4-0-benzyl-2,2'-di-O-methyleriodermate (125) (67o/o) crystallized as small 
colourless prisms, m.p. 98° (Found: C, 65.8; H, 6.1; Cl, 6.6. C29H31 Cl07 requires 
66 
C, 66.1; H, 5.9; Cl, 6.7%). 1 H n.m.r. (CDCI3) o 2.21 (12H), 2.52, both s, ArCH3 
x 5; 3.80 (6H), s, OCH3 x 2; 3.95, s, C02CH3; 4.99, s, OCH2; 7.50, s, C6H5. 
Mass spectrum: mlz 526 (M, < 0.1%), 303 (100). 
Methyl 2 ,2 '-di-0-methyleriodermate (96) ( 45%) crystallized as colourless needles, 
m.p. 168° (Found: C, 60.4; H, 5.9; Cl, 8.3. Cz2H25Cl07 requires C, 60.5; H, 5.8; 
Cl, 8.1 %). lH n.m.r. (CDCl3) o 2.20 (9H), 2.27, 2.48 each s, ArCH3 x 5; 3.78, 
3.82, both s, OCH3 x 2; 3.92 s, C02CH3; 5.98, s, OH. Mass spectrum: mlz 436 
(M, 0.05%), 215 (32), 214 (11), 213 (100), 193 (12), 170 (5), 91 (5). Standard RF 
values: RF(A) 66; RF(B*) 47; RF(C) 58. 
Methyl Eriodermate (92) 
Methyl 2,4-di-O-benzyleriodermate (121) (58%) crystallized as small colourless 
prisms, m.p. 140° (Found: C, 69.0; H, 5.7; Cl, 6.2. C34H33CI07 requires C, 69.3; 
H, 5.7; Cl, 6.0% ). 1 H n.m.r. (CDCI3) o 2.03, 2.10, 2.23, 2.40, 2.58, each s, ArCH
3 
x 5; 3.97, s, OCH3; 5.00 (4H), s, OCH2 x 2; 7.40, s, 7.47, m, c6H5 x 2. Mass 
spectrum: mlz 588 (M, 2%), 91 (100). 
Methyl eriodermate (92) (81 %) crystallized as colourless prisms, m.p. 165° 
(Found: C, 58.9; H, 5.2; Cl, 8.5. C20H21 Cl07 requires C, 58.8; H, 5.2; Cl, 8.7%). 
I H n.m.r. (CDCl3) 8 2.08 (6H), 2.20, 2.48, 2.80, each s, ArCH3 x 5; 3.98, s, OCH3; 
6. 30, 11.21, 11. 83, each s, OH x 3. Mass spectrum: mlz 408 (M, 1. 9% ), 210 (29), 
201 (32), 200 (15), 199 (100), 198 (15), 179 (23), 178 (67), 170 (9), 151 (7), 150 (65), 
149 (10), 107 (16). Standard Rp values: Rp(A) 74; RF(B*) 79; Rp(C) 79. 
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Methyl 4-0-Methyleriodermate (94) 
Methyl 2-0-benzyl-4-0-methyleriodermate (123) (53%) crystallized as colourless 
needles, m.p. 172° (Found: C, 65.3; H, 5.9; Cl, 7 .0. C23H29Cl07 requires C, 65.6; 
H, 5.7; Cl, 6.9%). 1 H n.m.r. (CDCl3) 8 2.03, 2.10, 2.29, 2.40, 2.54, each s, ArCH3 
x 5; 3.88, S, OCH3; 3.98, S, C02CH3; 5.00, s, OCH2; 7.40, s, C6H5; 11.14, s, 
OH. Mass spectrum: mlz 512 (M, 0.1%), 91 (100). 
Methyl 4-0-methyleriodermate (94) (93%) crystallized as a colourless amorphous 
solid m.p. 124° (Found: C, 60.0; H, 5.6; Cl, 8.4. C21 H23Cl07 requires C, 59.7; H, 
5.5; Cl, 8.4%). lH n.m.r. (CDCl3) 8 2.08 (6H), 2.21, 2.46, 2.82 each s, ArCH3 x 5; 
3.88, s, OCH3; 3.91, s, C02CH3; 5.98, 11.23, 11.64, each s, OH x 3. Mass 
spectrum: mlz 422 (M, 1.3%), 215 (33), 214 (15), 213 (100), 212 (13), 211 (5), 210 
(28), 184 (10), 179 (23), 178 (62), 150 (67), 149 (14), 141 (6), 122 (5), 121 (7), 107 
(11), 91 (11). Standard RF values: RF(A) 84; RF(B*) 87; Rp(C) 87. 
Methyl 2'-0-Methyleriodermate (95) 
Methyl 2,4-di-O-benzyl-2'-0-methyleriodermate (124) (60%) was obtained as a 
sticky colourless glass which eventually crystallized as colourless prisms, m.p. 106° 
(Found: C, 69.4; H, 6.1; Cl, 6.0. C3 5H3 5C107 requires C, 69.7; H, 5.9; Cl, 
5.9%). 1 H n.m.r. (CDC13) 8 2.03, 2.08, 2.15, 2.23, 2.58, each s, ArCH3 x 5; 3.73, 
s, OCH3; 3.92, s, C02CH3; 4.98, 5.01, both s, OCH2 x 2; 7.40, s, 7.50, m, C6H5 x 
2. Mass spectrum: mlz 601 (M, <0.01%), 91 (100). 
Methyl 2'-0-methyleriodermate (95) (91 %) crystallized as colourless prisms, m.p. 
172° (Found: C, 59.8; H, 5.3; Cl, 8.5. C21 H23Cl07 requires C, 59.7; H, 5.5; Cl, 
8.4%). lH n.m.r. (CDCI3) 8 2.07, 2.10, 2.22 (6H), 2.81, each s, ArCH3 x 5; 3.80, 
s, OCH3; 3.97, s, C02CH3; 6.32, 11.83, both s, OH x 2. Mass spectrum: mlz 422 
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(M, 1.4%), 225 (6), 224 (47), 201 (29), 200 (13), 199 (87), 198 (12), 194 (12), 193 
(100), 192 (23), 178 (5), 177 (12), 170 (7), 163 (9), 150 (12), 149 (11), 135 (8), 134 
(11), 121 (6), 107 (13), 91 (13). Standard Rp values: Rp(A) 70; Rp(B*) 60; RF(C) 
67. 
Methyl Norobtusatate (97) 
As the reactants were not completely miscible the condensation time was extended 
to 27 h. Separation by radial chromatography was difficult as ( 129) was rather insoluble 
in the ethyl acetate-light petroleum eluant. Methyl 4-0-benzylnorobtusatate (129) 
crystallized in masses composed of tiny fluffy crystals, m.p. 172° (Found: C, 68.8; H, 
5.6. C25H2407 requires C, 68.8; H, 5.5%). 1H n.m.r. (CDCl3) 8 2.17, 2.57, 2.63, 
each s, ArCH3 x 3; 3.99, s, OCH3; 5.18, s, OCH2; 6.45, s, HS; 6.61, 6.76, both d, 
J 2.5 Hz, H3',H5'; 7.44, s, C6H5; 11.60, 11.76, both s, OH x 2. Mass spectrum: 
mlz 436 (M, 0.1 %), 150 (100). 
Methyl norobtusatate (97) (98o/o) crystallized as colourless fluffy hair-like crystals, 
m.p. 151° (Found: C, 62.1; H, 5.3. C13H1307 requires C, 62.4; H, 5.2%). 1H 
n.m.r. (CDC13) 8 2.10, 2.58 (6H), both s, ArCH3 x 3; 4.01, s, OCH3; 6.42, s, H5; 
6.68, 6.75, both d, J 2.5 Hz, H3',H5'; 11.74, s, OH. Mass spectrum: mlz 346 (M, 
1 %), 150 (100). Standard Rp values: Rp(A) 57; Rp(B*) 55; Rp(C) 48. This 
compound proved dissimilar from any of the natural esters-occurring in the Erioderma sp. 
Methyl 5-Chloronorobtusatate (98) 
Methyl 3,4-di-O-benzyl-5-chloronorobtusatate (126) (94%) crystallized as 
colourless prisms, m.p. 113° (Found: C, 68.2; H, 5.2; Cl, 6.5. C32H29Cl07 requires 
C, 68.5; H, 5.2; Cl, 6.3%). 1 H n.m.r. (CDC13) 8 2.18, 2.41, 2.43, each s, ArCH3 x 
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3; 3.89, s, OCH3; 4.88, 4.90, both s, OCH2 x 2; 6.35, 6.58, both d, J 2.5 Hz, 
H3',H5'; 7.33, 7.38, both s, C6H5 x 2; 11.47, s, OH. Mass spectrum: mlz 560 (M, 
0.4%), 91 (100). 
Methyl 5-chloronorobtusatate (98) (94%) crystallized in colourless fine needles, 
m.p. 164° (Found: C, 57.1; H, 4.7; Cl, 9.7. C13H17Cl07 requires C, 56.8; H, 4.5; 
Cl, 9.3%). lH n.m.r. (CDC13) 8 2.19, 2.58, 2.72, each s, CH3 x 3; 3.99, s, OCH3; 
6.28, s, OH; 6.60, 6.74, both 8, J 2.5 Hz, H3',H5'; 11.30, 11.60, both s, OH x 2. 
Mass spectrum: mlz 381 (M, 0.2%), 201 (17), 200 (10), 199 (54), 198 (17), 182 (38), 
170 (11), 151 (31), 150 (100), 142 (5), 122 (48), 121 (7), 107 (9). Standard RF values: 
RF(A) 69; RF(B*) 64; RF(C) 72. 
Methyl 5-Chloro-4-0-demethyl-2 ,2 '-di-0-methylbarbatate (99) 
Methyl 4-0-benzyl-5-chloro-2,2'-di-O-methylbarbatate (127) (72%) crystallized as 
colourless plates, m.p. 106° (Found: C, 65.9; H, 5.8; Cl, 7 .0. C28H28Cl07 requires 
C, 65.6; H, 5.7; Cl, 6.9%). 1 H n.m.r. (CDC13) 8 2.23 (6H), 2.30, 2.48, each s, 
ArCH3 x 4; 3.83, s, OCH3 x 2; 3.92, s, C02CH3; 4.90, s, OCH2; 6.80, s, H; 
7 .20-7 .60, m, C6H5. Mass spectrum: mlz 511 (M, 0.5% ), 303 ( 100). 
Methyl 5-chloro-4-0-demethyl-2,2'-di-O-methylbarbatate (99) (100%) crystallized 
as colourless needles, m.p. 129° (Found: C, 59.4; H, _5.6; Cl, 8.4. C21 H23Cl07 
requires C, 59.7; H, 5.5; Cl, 8.4% ). 1 H n.m.r. (CDCI3) 8 2.20, 2.25, 2.32, 2.47, 
each s, ArCH3 x 4; 3.84, 3.87, both s, OCH3 x 2; 3.97, s, C02CH3; 6.00, s, OH; 
6.86, s, HS'. Mass spectrum: mlz 422 (M, <0.02%), 216 (5), 215 (45), 214 (16), 213 
(100), 179 (9), 170 (7), 91 (5). Standard Rp values: Rp(A) 66; RF(B*) 47; Rp(C) 
59. 
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Methyl 2',4-di-0-Methyleriodermate (100) 
Methyl 2-0-benzyl-2 ',4-di-0-methyleriodermate ( 128) (82 % ) crystallized as 
colourless prisms, m.p. 139° (Found: C, 66.0; H, 6.0; Cl, 7.0. C29H31 Cl07 
requires C, 66.1; H, 6.0; Cl, 6.7%). lH n.m.r. (CDCl3) 8 2.00, 2.04, 2.12, 2.27, 
2.51, each s, ArCH3 x 5; 3.68, 3.81, each s, OCH3 x 2; 3.88, s, C02CH3; 4.91, s, 
OCH2; 7.29, s, C6H5. Mass spectrum: mlz 526 (M, 0.03%), 91 (100). 
Methyl 2 ',4-di-0-methyleriodermate ( l 00) (86%) crystallized as colourless 
prisms, m.p. 161 ° (Found: C, 60.5; H, 6.0; Cl, 8.4. C22H25Cl07 requires C, 60.5; 
H, 5.8; Cl, 8.1 % ). 1 H n.m.r. (CDCl3) 8 2.02, 2.08, 2.20 (6H), 2.79, each s, ArCH3 
x 5; 3.74, 3.83, both s, OCH3 x 2; 3.90, s, C02CH3; 11.43, s, OH. Mass spectrum: 
mlz 436 (M, 0.5%), 224 (21), 215 (33), -214 (13), 213 (100), 212 (7), 194 (6), 193 
(45), 192 (11), 184 (6), 177 (5), 150 (5), 149 (5), 91 (12). Standard RF values: RF(A) 
74; RF(B*) 61; RF(C) 68. 
Methyl 2,4-di-O-Methyleriodermate (101) 
Methyl 2,4-di-O-methyleriodermate (101) (66%) crystallized as colourless prisms, 
m.p. 168° (Found: C, 60.7; H, 5.8; Cl, 8.5. C22H25Cl07 requires C, 60.5; H, 5.8; 
Cl, 8.1 %). 1 H n.m.r. (CDCI3) 8 2.19 (6H), 2.28, 2.47 (6H), each s, ArCH3 x 5; 
3.79, 3.82, both s, OCH3 x 2; 3.92, s, C02CH3; 1 l.04r s, OH. Mass spectrum: mlz 
436 (M, 2.2%), { 438 (0.7)} 229 (34), 228 (12), 227 (100). Standard RF values: 
RF(A) 76; RF(B*) 62; RF(C) 76. 
_J 
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H.p.l.c. RT values for synthetic and natural esters. 
RT (min) 
Ester synthetic natural 
Methyl barbatate (89) 9.50 9.50 
Methyl 4-0-demethylbarbatate (90) 5.93 5.91 
Methyl 5-chloro-4-0-demethylbarbatate (91) 7.37 7.31 
Methyl eriodermate (92) 6.81 6.76 
Methyl 2-0-methyleriodermate (93) 5.69 5.65 
Methyl 4-0-methyleriodermate (94) 9.54 9.52 
I· Methyl 2'-0-methyleriodermate (95) 5.58 5.61 
Methyl 2,2'-di-O-methyleriodermate (96) 4.92 4.91 
Methyl norobtusatate (97) 4.82 
Methyl 5-chloronorobtusatate (98) 5.60 5.63, 5.59 
Methyl 5-chloro-4-0-demethyl-2,2'-di-O-methylbarbatate (99) 4.59 
Methyl 2',4-di-0-methyleriodermate (100) 7.64 
Methyl 2,4-di-O-methyleriodermate (101) 8.51 
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Chapter 3 
New Fully Substituted Depsides from the Lichen Pseudocyphellaria 
pickeringii 
Introduction 
In the course of his continuing chemotaxonomic investigation of Australasian 
Pseudocyphellaria lichens, Wilkins noted the presence of a series of new aromatic 
substances in collections of Ps. pickering ii . Since a limited amount of the lichen material 
was available a number of micro-extractions with acetone were carried out at room 
temperature, and the combined extracts separated by a combination of radial and preparative 
layer chromatography on silica gel. Three of the eight metabolites recovered proved to be 
identical with compounds of established structure, namely pseudocyphellarin A (77), 
phenarctin (131) and nephroarctin (133). 
The spectral properties of two of the new metabolites corresponded closely with 
those reported for pseudocyphellarin A (77)46 and phenarctin ( 131),51 except for the 
appearance of an additional methoxy signal in their 1 H n.m.r. spectra. From an 
examination of the mass spectral fragmentation patterns Wilkins deduced that in each case, 
the additional methoxy group was associated with the B-ring of the new depsides. Hence 
they could be formulated as 2'-0-methylpseudocyphellarin A (134) and 
2'-0-methylphenarctin (135) respectively. 
A further two of the new substances displayed mass spectral fragmentation patterns 
which corresponded closely with those determined for pseudocyphellarin A (77) and its 
2'-0-methyl ether ( 134), but the 1 H n.m.r. spectra of these compounds were characterised 
by a downfield aryl methyl group signal. This downfield shift could be rationalised if the 
C-6 methyl group was flanked by both an aldehyde group and the depside ester linkage. 
Wilkins tentatively formulated these compounds isopseudocyphellarin A ( 136) and 
2'-0-methylisopseudocyphellarin A (137) respectively. 
Mc 
HO 
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HO 
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C0-0 
OH Mc 
CHO Me 
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(134) R = Me 
Mc Me 
co-o 
OH Me 
CHO Me 
(131) R = H 
(135) R = Me 
Me Me 
co-o 
OH Me 
Me Me 
(136) R = H 
(137) R = Me 
Mc Me 
C0-0 
OH Me 
CHO Me 
(133) R = H 
(138) R = Cl 
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Mass spectroscopic analysis showed that the fifth new substance contained a 
chlorine atom, but otherwise the mass spectral and 1 H n.m.r. properties of thi s con1pound 
corresponded closely with those determined for nephroarctin (131 ). Wilkins thus 
concluded that this compound was probably l '-chloronephroarctin (138). 
Total Synthesis of the New Depsides 
The total synthesis of each of the above new compounds (134) - (138) was 
undertaken in the present work to confirm the tentative structures assigned as discussed 
above. Hence it was neccessary to prepare suitably protected benzoic acids and phenols as 
A- and B-ring precursors respectively. In this case the B-ring moieties contained neither 
free carboxylic acid groups nor non-intramolecularly H bonded hydroxy groups and thus 
needed no protection. The A-ring compounds were prepared from methyl orsellinate (115) 
and ethyl 2,4-dihydroxy-3,6-dimethylbenzoate (102), with the 2-hydroxy functionalities 
remaining unprotected. The ease in preparation of these unprotected A-ring precursors was 
felt to compensate for the lower yields expected during the condensation of the A- and 
B-ring intermediates to form the depsides. As mentioned previously, such losses are due 
SCHEME28 
Me Me 
C02Et OHC C02Et 
HMTA 
CF3COOH 
HO OH HO OH 
Me Me-
(102) (141) 
Me 
OHC C02H 
cone. 
H2S04 
HO OH 
Me 
(139) 
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to s n1c self-condensation of the A-ring reactant, even when the remaining hydroxy group 
is deactivated by intramolecular H-bonding. 
The synthesis of two of the A-ring precursors, 3-formyl-4,6-dihydroxy-2,5-
diniethylbenzoic acid (139) from ethyl 2,4-dihydroxy-3,6-dimethylbenzoate (102), and 
3 ,5-dif ormyl-2,4-dihydroxy-6-methy lbenzoic acid (140) from methy 1 orselli nate ( 115) 
respectively is outlined in Schemes 28 and 29. 
Mc 
C02Me 
HO OH 
(115) 
SCHEME29 
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In 1981 Sala and Sargeant47 reported a simple, two step method of formylating 
methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate ( 117) by treatment with 
hexamethylenetetramine in trifluoroacetic acid. Using these reagents it was possible to 
simultaneously introduce two aldehyde substituents into methyl orsellinate (115) to give the 
dialdehyde (142), which on hydrolysis with boron tribromide afforded the A-ring 
precursor (140) (Scheme 29). 
The simultaneous formylation of the 3 and 5 positions of methyl orsellinate (115) 
with these reagents can be rationalised if one considers the mechanism of this substitution 
I 
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reaction (Scheme 30). The hexamethylenetetramine [(CH2)6N4] reagent in the presence 
of acid is first converted into an electrophile (a) which substitutes the free position of the 
aromatic ring to form a tertiary amine of the form (b). On workup this intermediate 
undergoes hydrolysis to the primary amine (c) which in turn is converted to a Schiff base 
(d) with formaldehyde liberated from the reagent (hexamethylenetetramine). The key step 
in this Sommelet reaction52 follows - transfer of hydrogen from a second mole of the amine 
(c) to the Schiff base (d) to form a second imine (e). The latter imine is ultimately 
hydrolysed by water to form the desired aldehyde (f). The ability of this method to effect 
disubstitution results from the fact that the intermediate (b) is activated to further 
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electrophilic substitution in contrast to a normal formyl substituent which is electron 
withdrawing and deactivating. 
This method proved more efficient (more rapid and with fewer steps) than the 
n1ethod previously used to synthesise this compound.51 
The third A-ring precursor, 3-fonnyl-2,4-dihydroxy-5,6-din1ethylbenzoic acid (143) 
was prepared by the literature method.46 
Me 
HO 
Mc 
CHO 
(143) 
Me 
HO 
Me 
Me 
(116) R = H 
(118) R = Me 
Two of the B-ring precursors, namely methyl 2,4-dihydroxy-3,5,6-
trin1ethylbenzoate (116) and methyl 4-hydroxy-2-methoxy-3,5,6-trimethylbenzoate (118), 
had been prepared previously (see Chapter 2, pp 45-47). 
Me 
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A comparison of the structure of the third B-ring precursor, 
4-chloro-3-methoxy-2,5,6-trimethylphenol (144), with that of ethyl 
2-benzyloxy-5-chloro-4-methoxy-3,6-dimethylbenzoate (113), (Chapter 2, pp 44-45) 
showed that it should be possible to obtain (144) by converting the ester group of (113) to 
a methyl group, followed by hydrogenolysis of the benzyloxy group. This route is 
outlined in Scheme 31. Thus reduction of the ester (113) with lithium aluminium hydride 
Cl 
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MeO 
Mc 
Mc 
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afforded the benzyl alcohol (145). This alcohol was then silylated by treatment with 
chlorotrimethylsilane and hexamethyldisilazane in pyridine to give the unstable 
trin1ethylsilyl ether (146), which was in turn reduced by addition of lithium aluminium 
hydride-aluminium chloride to give the trimethyl compound (147) . . Hydrogenolysis of 
4-benzyloxy-2-methoxy-3,5,6-trimethylchlorobenzene (147) then gave the desired key 
intermediate, 4-chloro-3-methoxy-2,5,6-trimethylphenol (144). 
As shown in Scheme 32 subsequent condensation of the benzoic acids (139), (140) 
and (143) with the appropriate methyl esters (116), (118) and (144) in the presence of 
trifluoroacetic anhydride gave the depsides (134), (135), (136), (137) and (138). These 
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synthetic esters proved to be identical with the corresponding natural esters ( 1 H n.n1.r., 
m.s., t.l.c., h.p.1.c .) isolated by Wilkins. 
SCHEME32 
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Spectra of the New Depsides 
The 1 H n.m.r. spectra of these depsides has been discussed above. 
The major mass spectral fragmentation pathways exhibited by the depsides (134) -
(137) are illustrated in Scheme 33. As has been observed previously for similar 
depsides,41 the main fragmentation pathway appears to be via route z involving 
acyl-oxygen cleavage of the depside ester bond to give ring-A fragment ions (V) at mlz 193 
for depsides (134), (136) and (137) and at mlz 207 for depside (135). Indeed the base 
peak in the spectra of each of the depsides (134) - (137) was observed at mlz 193. 
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Depside cleavage may also be accompanied by hydrogen transfer (i.e. route x) 
giving rise to daughter ions (VI) at mlz 224, 210 arising from ring-B. The first of these 
ions may fragment further with loss of OMe giving rise to a daughter ion (VII) at mlz 193, 
or with loss of MeOH to a daughter ion (VIII) at mlz 192. The loss of MeOH from the mlz 
210 ion gives rise to the fragment (IX) at mlz 178. The fragment ions observed at mlz 164 
and 150 may be due to the loss of CO from the daughter ions (VIII) at mlz 192 and (IX) at 
178 respectively. 
The spectrum of depside (138) exhibited a base peak at mlz 200 (Scheme 34) arising 
from depside ester cleavage accompanied by hydrogen transfer (route x). That this is due 
to an ion (X) of B-ring origin is confirmed by the appearance of an accompanying isotopic 
ion at mlz 202 (due to the 37 Cl isotope). These daughter ions may fragment further with 
loss of a methyl group giving rise to ions (XI) at mlz 185 and 187 respectively, while loss 
of a chlorine atom would account for the peak observed at mlz 165. The daughter ion 
(XII) observed at mlz 178 could arise from depside ester cleavage accompanied by 
hydrogen transfer followed by loss of CO from the resultant ring-A daughter ion (XIII) at 
mlz 206. The small peak at mlz 207 is due to a ring-A fragment (XIV) arising from route 
z. 
Comparison of Natural and Synthetic Material 
Comparative h.p.l.c. and t.l.c. of the synthetic depsides (134), (135), (136), (137), 
and (138) with extracts of Pseudocyphellaria pickering ii established that these depsides 
were identical with the corresponding natural esters in the lichen. This was further 
confirmed by comparison of the 1 H n.m.r. and mass spectra of the synthetic and natural 
material. 
Thus the synthesis of 2'-0-methylpseudocyphellarin A (134), 2'-0-methyl-
phenarctin (135), isopseudocyphellarin A (136), 2'-0-methylisopseudocyphellarin A (137) 
and l 'chloronephroarctin ( 138) confirmed the structures of these natural products. 
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Biosynthctic Implications 
As with a number of the new depsides discussed in Chapter 2, the depsides (134) -
(138) are also fully substituted bringing the total of such compounds now isolated to 
thirteen. This lichen species must also contain a powerful methylating enzyme as 
evidenced by the multiple C-methylation which n1ust have occurred prior to cyclization and 
aromatization, and also by the 0-methylation after aromatization. This 0-methylation 
occurs only at the C02H and 2'-0H groups but not at either of the A-ring hydroxy groups. 
However in this species the subsequent selective oxidation of aromatic C-methyl 
groups from -CH3 to -CHO was also observed. Pseudocyphellarin B (132) with the 
intermeruate 3-CH20H group has been isolated in an allied species. 
The formation of 1 '-chloronephroarctin (136) is assumed to involve decarboxylation 
of the l '-C02H of the appropriate precursor followed by chlorination of the then 
unsubstituted ! '-position. 
85 
Experimental 
The general experimental details have been given previously in Chapter 2. 
Synthesis 
Ethyl 3-Formyl-4,6-dihydroxy-2,5-dimethylbenzoate (141) 
A mixture of ethyl 2,4-dihydroxy-3,6-dimethylbenzoate(l02) (3.21 g, 15.3 mmol), 
and hexamethylenetetramine (2.55g, 18.3 mmol) was stirred in trifluoracetic acid ( 45 ml) 
at 0° until almost all was dissolved. Then the solution was stirred and heated under reflux 
at 95-100° for 12 h. The solvent was removed and the residue poured into water (90 ml) 
and heated at 55-60° for 6 h. After cooling in ice, the orange product was filtered off, 
washed with water, dried on the water pump and evaporated twice with toluene to remove 
any residual water. The crude product (2.41 g) was purified on a silica gel column using 
5% ethyl acetate-light petroleum as eluant. The product (1.53 g, 42%) crystallized from 
ethyl acetate-light petroleum as colourless needles of ethyl 3-formyl-4 ,6-dihydroxy-2 ,5-
dimethylbenzoate (141), m.p. 138° (Found: C, 60.7; H, 5.9. C12H1405 requires C, 
60.5; H, 5.9% ). l H n.m.r. (CDCl3) 8 1.43, t, J 7 Hz, OCH2CH3; 2.07, 2.77, both s, 
ArCH3 x 2; 4.50, q, J 7 Hz, OCH2CH3; 10.41, s, CHO; 12.42, 13.32, both s, OH x 2. 
Mass spectrum mlz 238 (M, 31 %), 164 (100). 
3-F ormyl-4 ,6-dihydroxy-2 ,5-dimethylbenzoic Acid (139) 
A solution of ethyl 3-formyl-4,6-dihydroxy-2,5-dimethylbenzoate (141) (0.86 g, 
3.6 mmol) in cold concentrated sulfuric acid was stored at 5°C for 16 h. The solution was 
then poured into ice-water, extracted with ether and the ethereal solution extracted several 
times with saturated sodium hydrogen carbonate. The combined sodium hydrogen 
carbonate extracts were acidified with dilute hydrochloric acid, extracted with ether and the 
ethereal layer washed with a very small amount of ice-cold water and dried (MgS04). The 
solvent was evaporated and the residue was applied to a short column of silica gel and 
eluted with ethyl acetate.The major band afforded the desired product ( 139) (0.59 g, 78o/o) 
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which appeared pure as shown by t.l.c. and 1 H n.m.r. A small portion was crystallized 
from methanol to give 3 jormyl-4 ,6-dihydroxy-2 ,5-dimethylbenzoic acid ( 139), as almost 
colurless needles, m. p. 217° (dee.) (Found: C, 57 .1; H, 4. 7. C 1 oH 1 oO 5 requires C, 
57.1; H, 4.8%). 1H n.m.r. (CDCl3/CD3SOCD3) 8 2.06, 2.88, both s, ArCH3 x 2; 
6.73, s, OH; 10.50, s, CHO; 13.48, s, OH. Mass spectrum mlz 210 (M, 56%), 164 
(100). 
Methyl 3 ,5-Diformyl-2 ,4-dihydroxy-6-methylbenzoate ( 142) 
Methyl orsellinate (115) (1.39 g, 7.63 mmol) and hexamethylene tetramine (5.63 g) 
were dissolved with stirring in trifluoroacetic acid (99 ml) which had been pre-cooled in an 
ice-salt bath. The mixture was allowed to reach room temperature and then heated under 
reflux (bath temp. 95-100°) for 44 h. The solvent was then evaporated and the residue 
heated with water (200 ml) at 60-65° for 6 h. · The mixture was then cooled in an ice-bath, 
the liquid decanted off and the sticky solid washed several times with water and dissolved 
in ethyl acetate. The ethyl acetate solution was evaporated and the remaining water 
azeotroped with toluene. The crude product (1.25g, 69%) was purified by radial 
chromatography (Si02) using 2% acetic acid-20% ethyl acetate-light petroleum followed by 
ethyl acetate as eluant. After crystallization from dichloromethane-light petroleum methyl 
3,5- diformyl-2,4-dihydroxy-6-methylbenzoate (142) (0.59 g, 33%) was obtained as long, 
pale cream prisms, m.p. 159°, (lit.51 155.5-157°) after crystallization from dichloro-
methane-light petroleum (Found: C, 55.4; H, 4.2. Calculated for C11 H1006 C, 55.5; 
H, 4.2% ). 1H n.m.r. (CDCl3) 8 2.52, s, ArCH3; 3.90, s, OCH3; 10.15, 10.31, both 
, CHO x 2; 13.16, 13.78, both s, OH x 2. Mass spectrum mlz 238 (M, 21 o/o ), 178 
( 100). 
3 ,5-Diformyl-2 ,4-dihydroxy-6-methylbenzoic Acid ( 140) 
A solution of boron tribromide (7.4 g) in anhydrous 1,2-dichloroethane (20 ml) was 
added dropwise to a stirred solution of methyl 3,5-diformyl-2,4-dihydroxy-6-methyl-
benzoate (142) (520 mg, 2.2 mmol) in 1,2-dichloroethane (60 ml) over 25 n1in. at room 
temperature. The solution was then heated under reflux for 3 h. The reaction mixture was 
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poured into ice containing concentrated hydrochloric acid (5 ml) and extracted with ether. 
The ethereal extract was washed with a little ice-cold water, dried (MgS04) and 
concentrated. The crude brown product applied to a short silica column and eluted with 
ethyl acetate. The major band afforded 3,5-diformyl-2,4-dihydroxy-6-methylbenzoic acid 
(140) (400 mg, 82%) as a yellow solid m.p. 170° (lit.51 183-185°). lH n.m.r.51 (CDC13/ 
CD3SOCD3) 8 2.69, s, ArCH3; 9.4, vbs, C02H; 10.22, 10.32, both s, CHO x 2; 
13.74, s, OH (identical with that reported by Hamilton and Sargent51). 
2-Benzyloxy-5-chloro4-methoxy-3 ,6-dimethylbenzylalcohol (145) 
A solution of ethyl 2-benzyloxy-5-chloro-4-methoxy-3,6-dimethylbenzoate (113) 
(0.70 g, 2 mmol) in anhydrous ether (50 ml) was added dropwise to a stirred solution of 
lithium aluminium hydride (0.152 g, 4 mmol) in anhydrous ether (81 ml). The mixture 
was then heated under reflux for 1.25 h. After cooling in an ice bath, the excess lithium 
aluminium hydride was destroyed by slow addition of hydrochloric acid (4M). The 
mixture was extracted with ether, the ethereal extract washed with water, with saturated 
brine and dried (MgS04). Evaporation of the solvent afforded 2-benzyloxy-5-chloro-4-
methoxy-3 ,6-dimethylbenzyl alcohol ( 145) (0.60 g, 97% ), which crystallized from 
dichloromethane-light petroleum as colourless needles, m.p. 84° (Found: C, 66.8; H, 6.3; 
Cl, 11.9. C17H19Cl03 requires C, 66.6; H, 6.2; Cl, 11.6%). 1H n.m.r. (CDCI3) 8 
2.23, 2.40, both s, ArCH3 x 2; 3.78, s, OCH3; 4.63, s, ArCH20H; 4.80, s, OCH2; 
7.37, s, C6H5. Mass spectrum m!z 306 (M, 2.3o/o), 91 (100). 
4-Benzyloxy-2-methoxy-3 ,5 ,6-trimethylchlorobenzene ( 147-) 
Chlorotrimethylsilane (2 ml) and hexamethyldisilazane (1 ml) were added to a 
solution of 2-benzyloxy-5-chloro-4-methoxy-3,6-dimethylbenzyl alcohol (145) (0.65 g, 
2.1 mmol) in dry pyridine (5 ml) in a stoppered flask, and stood at room temperature for 
l h. The pyridine was then removed by evaporation-residual traces of pyridine removed 
by azeotroping three times with anhydrous toluene (15 ml). 
Anhydrous ether (15 ml) was added to the residue and the white suspension filtered 
through a short column of silica gel and the column washed with further anhydrous ether 
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( 10 ml). The combined ethereal filtrates were stoppered and a small sample removed for 
l H n.m.r. determination. 4-Benzyloxy-2-methoxy-3 ,6-dimethyl-5-(trimethylsilyloxy-
methyl)chlorobenzene (146) exhibited lH n.m.r. (CDCl3) o 2.08, 2.28, both s, ArCH3 
x 2; 3.62, s, OCH3; 4.53, s, OCH2; 4.69, s, ArCH20; 7.22, s, C6H5. 
The bulk of the reaction product was reduced immediately as follows. The filtrate 
was added dropwise over 10 min. with stirring to a mixture prepared by the addition of 
anhydrous aluminium chloride (3.2 g) to lithium aluminium hydride (0.4 g) in anhydrous 
ether (30 ml). The mixture was heated under gentle reflux for 1 h. After cooling and 
cautious addition of hydrochloric acid (4M), the mixture was diluted with water, extracted 
with ether, the ethereal extract washed with water, with saturated brine and dried (MgS04). 
The product was purified by radial chromatography (Si02) using 5% ethyl acetate-light 
petroleum as eluant. The first major fraction yielded 4-benzyloxy-2-methoxy-3 ,5 ,6-
trimethylchlorobenzene (147) (0.33 g, 54%) as a colourless oil, (which solidified as small, 
pale cream prisms on standing, m.p. 70°) (Found: C, 70.1; H, 6.6; Cl, 12.5. 
Cl ?H 19Cl02 requires C, 70.2; H, 6.6; Cl, 12.2% ). 1 H n.m.r. (CDCl3) o 2.21 (6H), 
2.30, both s, ArCH3 x 3; 3.77, s, OCH3; 4.72, s, OCH2; 7.39, s, C6H5. Mass 
spectrum mlz 290(M, 24.8%), 291 (47), 91 (100). 
The second major fraction yielded 4-chloro-3-methoxy-2,5,6-trimethylphenol (144) 
(0.06 g, 14%) as a colourless solid identical with the material prepared below. 
4-C hloro-3-methoxy-2 ,5,6-trimethylphenol ( 144) 
4-Benzyloxy-2-methoxy-3,5,6-trimethylchlorobenzene (147) (260 mg) was 
dissolved in ethyl acetate (30 ml) and stirred with 10% palladium-on-carbon ( 190 mg) in a 
hydrogen atmosphere for 18 h. The catalyst was filtered, the solvent evaporated and the 
residue purified by radial chromatography (Si02) using ethyl acetate-light petroleum as 
eluant to afford 4-chloro-3-methoxy-2,5,6-trimethylphenol (144) (132 mg, 74%), which 
crystallized from dichloromethane-light petroleum as almost colourless prisms, m.p. 121 ° 
(Found: C, 59.7; H, 6.6; Cl, 17.8. c1 oH l 3 Cl02 requires C, 59.9; H, 6.5; Cl , 
l 7.7o/o). l H n.m.r. (CDCl3) o 2.17 (6H), 2.29, both s, ArCH3 x 3; 3.73, s, OCH3; 
4.60, s, OH. Ma s spectrum mlz 200 (M, 100%), 201 (13). 
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Synthesis of Depsides - General Procedure 
The appropriate carboxylic acid, i.e. (139), (140), (143) and phenol, (116), (118), 
(144) (in equimolar proportions of ca. 0.5 mmol) were stirred in a solution of anhydrous 
toluene (9 ml) and trifluoroacetic anhydride (3 ml) at room temperature for 5.5 h. The 
solvent was removed under reduced pressure and the residue purified by passage through a 
small silica gel column with ethyl acetate as eluant and then by radial chromatography 
(Si02) using 5-10% ethyl acetate-light petroleum as eluant for (136) and (137), using 
10-50% ethyl acetate-light petroleum, and then 0.5% acetic acid-20% ethyl acetate-light 
petroleum as eluant for (135) and (138), and with 5-20% ethyl acetate-light petroleum as 
eluant for (134). The depsides obtained on evaporation of the solvent were crystallized 
from dichloromethane-light petroleum. Standard RF values were determined in three 
independent t.l.c. solvent systems: (A) toluene-dioxane-acetic acid (180:45:5); (B) 
hexane-methylt-butyl ether-formic acid (140:72: 18); and (C) toluene-acetic acid (200:30). 
Isopseudocyphellarin A (136) 
Isopseudocyphellarin A (136) (15%) crystallized as colourless prisms, m.p. 201 ° 
(dee.) (Found: mol. wt. 402.1315. C21H2203 requires mol. wt. 402.1314). 1H n.m.r. 
(CDCl3) 8 2.07 (6H), 2.10, 2.44, 2.97, each s, ArCH3 x 5; 3.96, s, OCH3; 10.38, s, 
CHO; 11.08, 12.16, 13.26, each s, OH x 3. Mass spectrum mlz 402 (M, 5.0%), 210 
(28), 194 (26), 193 (100), 192 (8), 191 (6), 179 (19), 178 (48), 164 (7), 150 (32), 149 
(8), 121 (5), 109 (6), 107 (8). Standard RF values: RF(A) 76; RF(B*) 61; RF(C) 78. 
This synthetic isopseudocyphellarin A (136) was identical ( 1 H n.m.r., m.s., t.l.c., 
h.p.l.c.) with a minor metabolite of Pseudocyphellaria pickeringii. 
2'-0-Methylisopseudocyphellarin A (137) 
2 '-0-M ethylisopseudocyphellarin A (137) ( 63%) crystallized as colourless plates, 
m.p. 171 ° (Found: C, 63.7; H, 5.9. c22 H24 03 requires C, 63.5; H, 5.8% ). 1 H n.m.r. 
(CDCI3) 8 2.03, 2.10 (6H), 2.19, 2.96, each s, ArCH3 x 5; 3.76, 3.91, both s, OCH3; 
10.38, s, CHO; 12.17, 13.27, both s, OH x 2. Mass spectrum mlz 416 (M, 0.9%), 224 
(28), 195 (6), 194 (38), 193 ( 100), 192 (22), 191 (8), 177 (7), 165 (5), 164 (9), 163 (9), 
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150 (7), 149 (6), 135 (7), 134 (6), 121 (5), 109 (8), 107 (7). StandardRp values: Rp(A) 
71; Rp(B*) 52; Rp(C) 60. This synthetic 2'-0-methylisopseudocyphel/arin A (137) was 
identical ( 1 H n.m.r., m.s., t.l.c., h.p.l.c.) with a minor metabolite of Pseudocyphellaria 
pickering ii. 
1 '-Chloronephroarctin (138) 
1 '-C hloronephroarctin (138) (38%) crystallized as colourless plates, m.p. 181 ° 
(Found: C, 58.7; H, 4.8. C20H 19Cl07 requires C, 59.1; H, 4.7%. Found: mol. wt. 
406.0819. C20H19Cl07 requires mol. wt. 406.0819). 1H n.m.r. (CDCl3) 8 2.19 (6H), 
2.33, 2.70, each s, ArCH3 x 4; 3.78, s, OCH3; 10.20, 10.33, both s, CHO x 2; 13.52, 
13.88, both s, OH x 2. Mass spectrum mlz 406 (M, 0.1 %), 207 (12), 202 (32), 201 
(12), 200 (100), 187 (9), 185 (29), 180 (6), 178 (16), 165 (12), 159 (15), 158 (5), 157 
(48), 152 (9), 151 (10), 135 (5), 122 (15), 121 (12), 107 (5), 105 (5). Standard Rp 
values: Rp(A) 69; Rp(B*) 54; Rp(C) 67. This synthetic J'-chloronephroarctin (138) 
was identical ( 1 H n.m.r., m.s., t.l.c., h. p.l.c.) with a minor metabolite of 
Pseudocyphellaria pickering ii. 
2 '-0-M ethylphenarctin ( 135) 
2'-0-Methylphenarctin (135) (29%) crystallized as almost colourless plates, m.p. 
166° (Found: C, 61.4; H, 5.4. c22H2209 requires C, 61.4; H, 5.2%). 1 H n.m.r. 
(CDCI3) 8 2.18 (9H), 2.72, both s, ArCH3 x 4; 3.73, 3.90, both s, OCH3; 10.21, 
10.37, both s, CHO x 2; 13.53, 13.90, both s, OH x 2. Mass spectrum mlz 430 (M, 
0.2o/o), 225 (8), 224 (58), 207 (14), 194 (12), 193 (100), _. 192 (23), 178 (17), 177 (12), 
163 (8), 151 (5), 150 (11), 149 (7), 135 (6), 134 (9), 121 (5), 105 (5). Standard RF 
values: RF(A) 64; Rp(B*) 28; Rp(C) 53. This synthetic 2'-0-methylphenarctin (135) 
was identical (1 H n.m.r., m.s. , t.l.c., h.p.l.c.) with a n1inor metabolite of 
Pseudocyphellaria pickeringii. 
2 '- 0-Methylpseudocyphellarin A (134) 
2'-0-Methylpseudocyphellarin A (134) (34%) crystallized as colourless plates, n1.p. 
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190° (Found: C, 63.8; H, 5.9. C22H240g requires C, 63.5; H, 5.8%). 1 H n.m.r. 
(CDCl3) 8 2.04, 2.08, 2.15, 2.18, 2.67, each s, ArCH3 x 5; 3.73, 3.90, both s, OCH3; 
10.38, s, CHO; 12.37, 13.07, both s, OH x 2. Mass spectrum mlz 416 (M, 0.2%), 225 
(6), 224 (48), 194 (12), 193 (100), 192 (31), 191 (5), 178 (6), 177 (10), 166 (8), 165 
(13), 164 (46) 163 (9), 150 (10), 149 (7), 136 (12), 135 (10), 134 (9), 121 (6), 108 (5), 
107 (8). Standard Rp values: Rp(A) 73; Rp(B*) 59; Rp(C) 66. This synthetic 2'-0-
methylpseudocyphel/arin A (134) was identical ( 1 H n.m.r., m.s., t.l.c., h.p.l.c.) with a 
minor metabolite of Pseudocyphellaria pickering ii. 
H.p.l.c. RT values for synthetic and natural esters. 
RT (min) 
Ester synthetic natural 
2'-0-methylpseudocyphellarin A (134) 7.54 7.55 
2'-0-methylphenarctin (135) 5.03 5.03 
isopseudocyphellarin A ( 136) 6.89 6.91 
2'-0-methylisopseudocyphellarin A (137) 5.67 5.67 
l '-chloronephroarctin (138) 6.83 6.84 
phenarctin ( 131) 5.77 5.77 
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Chapter 4 
The Synthesis of para-Sphaerophorol Depsides 
Introduction 
In 1984 Culberson et a!.28 reported the occurrence of five new depsides containing 
a 2-heptyl-4,6-dihydroxybenzoic acid (sphaerophorol) moiety, in effect homologues of 
sphaerophorin (148), which had been .known for many years. These depsides included 
4-0-demethy lsphaerophorin ( 149), isosphaeric acid ( 150), hyperlatolic acid (151 ), 
isohyperlatolic acid (152) and superlatolic acid (153). By the use of comparative t.l.c. 
and microhydrolysis, Culberson et a!.28 deduced the structures of these new depsides (as 
discussed in Chapter 1, p 30), but only the· structure of superlatolic acid, 53 had previously 
been confirmed by unambiguous synthesis. 
RO 
MeO 
Me 
C0-0 
OH 
(148) R = Me 
(149) R = H 
C0-0 
OH 
(150) R=Me 
(152) R = C5H 11 
(153) R = C7H15 
OH 
C02H 
R 
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C0-0 
McO OH 
(151) 
Synthesis of the Depsides (149) - (152) 
In order to confirm the structure of the depsides (149), (150), (151) and (152), the 
total synthesis of each was undertaken. 
SCHEME35 
C1H1s 
C02Et C02Et 
Me2S04 
HO OH 
K2C03 MeO OH 
(154) (157) 
KOH 
MeO 
(158) 
C7H15 C,H1s 
C02Et C02CH2Ph PhCH20Na 
PhCH20H 
HO OH HO OH 
(154) 
(161) 
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As in the previous syntheses it was neccessary to prepare suitably protected 
benzoic acid and phenols as the respective A- and B-ring precursors. As each of the 
depsides (149)-(152) was a free acid, the carboxylic acid groups on the B-ring precursors 
needed to be protected as benzyl ester groups, while the 4-hydroxy groups of the A-ring 
precursors were protected as 0-benzyl groups. In each case this prevented self 
condensation of either the B-ring or the A-ring precursors. The intramolecularly 
hydrogen bonded phenolic groups were not protected as such groups react only slowly 
during the condensation reaction. The primary starting materials used were ethyl 
2-heptyl-4,6-dihydroxybenzoate (154),54 ethyl 2,4-dihydroxy-6-pentylbenzoate (155)54 
and ethyl orsellinate (156).54 2-Heptyl-6-hydroxy-4-methoxybenzoic acid (158),53 
2-hydroxy-4-methoxy-6-pentylbenzoic acid (160),35 2,4-dibenzyloxy-6-methylbenzoic 
acid (162),55 2-benzyloxy-4-methoxy-6-methylbenzoic acid (163),56 benzyl 2-heptyl-
4,6-dihydroxybenzoate (164),53 benzyl 2,4-dihydroxy-6-pentylbenzoate (165)35 and 
benzyl orsellinate (166)41 were prepared by literature methods (Schemes 35,36 and 37). 
SCHEME36 
CsH11 C5H11 
C02Et C02Et 
Me2S04 KOH 
K2C03 
HO OH MeO OH 
(155) (159) 
McO 
(160) 
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SCHEME37 
Mc Mc 
C02Et C02Et PhCH 2Br 
K2C03 
HO OH PHCH2 0 OCH2 Ph 
(156) (161) 
Mc 
KOH 
(162) 
Mc Mc 
C02Et C02CH2Ph 
PhCH20Na 
PhCH20H 
HO OH HO OH 
(156) (166) 
Me 
MeO OCH2Ph HO 
(163) (165) 
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The condensation of the benzoic acids (] 58), (160), ( 162) and (163) with the 
appropriate benzyl esters (164 ), (165) and (166) in the presence of trifluoroacetic 
anhydride gave the depside esters, (167), (168), (169), (170), (171) and (172) 
(illustrated in Scheme 38). Subsequent hydrogenolysis of the latter afforded the free 
depsides (148), (149), (] 50), (151 ), (152) and (153). 
SCHEME38 
C02CH2Ph 
+ (CF3CO)i0 
HO OH 
C0-0 
R1 R2 R3 ~ 
(163) + (164) _.. (167) CH2Ph Me Me C7H1s 
(162) + (164) _.. (168) CH2Ph CH2Ph Me C,H1s 
(158) + (166) -- (169) H Me C7H1s Me 
(160) + (164) --(170) H Me CsH11 C7H1s 
(158) + (165) ----(171) H Me C7H1s CsH11 
(158) + (164) -- (172) H Mc C7H1 s C7H1s 
Spectra of th.e New Depsides 
Th~ 1 H n.m.r. and mass spectra for these synthetic depsides were consistent with 
those observed previously for similar compounds.53 The molecular ion peaks were not 
observed for either the depside esters (168), (169) or (171) (as are often seen) or the 
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SCHEME39 
McO OH McO OH 
(XV) 
rout/ 
m~T + R1 R1 col o C02H route y 
McO OH C02H McO OH 
R1 R2 R2 (XVI) (148) Me C1H1s 
(150) C1H1s Me 
(151) C5H11 C1H1s 
(152) C1H1s CsH11 
(153) C1H1s C1H1s 
R1 0 OJ~ \\ uo 
A 
_r; 
McO C02H 0 
R1 R2 R2 
(148) Me C7H1s 
(150) C7H1s Me HO 0 + 
(151) CsH11 C1H1s route x 
(152) C1H1s C5H11 
(153) C1H1s C1H1s C 
~o 
R2 
(XX) 
R1 + HO 0 + 
c~ 
0 'H HO OH 
+ .,,...OH -CO2 
C 
II McO 0 R2 0 
R2 
(XVII) (XVill) (XIX) 
98 
actual depsides themselves that is (148), (149), (150), (151), (152) and (153). The 
major mass spectral fragmentation pathways exhibited by the depsides (148) and 
(150)-(152) are illustrated in Scheme 39. There does not appear to be any one main 
fragmentation pathway for all of the depsides. Fragmentation via route z involves 
cleavage of the depside ester bond and for depside (151) gives a daughter ion (XV) at mlz 
221 (the base peak) due to the ring-A fragment. Depsides (150) and (152) also fragment 
via this route leading to analogous daughter ions (XV) at mlz 249. However the latter 
two depsides also fragment by route y leading to daughter ions (XVI) at mlz 266, and via 
route x (involving depside ester cleavage with hydrogen transfer) to give daughter ions 
(XVII) at mlz 248, both having been derived from ring-A. The latter fragmentation route 
also gives ions (XVIII) arising from ring-B. These are observed at mlz 168 for depside 
(150) and at mlz 224 for depside (152). All the depsides except (151) show this 
fragmentation pattern. Daughter ions (XIX) arising from further fragmentation of the 
B-ring by loss of CO2 are observed at mlz 208 in the spectra of depsides (148), (149) 
and (153). Depsides (152) and (150) exhibit analogous daughter ions (XIX) at mlz 180 
and mlz 124 respectively. Depsides (152) and (150) also exhibit daughter ions (XX) at 
mlz 150 (the base peak) and mlz 206 respectively due to loss of H20 from the B-ring 
fragment. 
Comparison of Natural and Synthetic Material 
Comparative t.l.c. and h.p.l.c. of the synthetic depsides (148)-(152) with extracts 
of the lichen material confirmed their natural occurrence. Thus it was shown that 
Fuscidea viridis Tonsb. contained hyperlatolic acid ( 151) and isohyperlatolic acid ( 152); 
that Dimelaena oriena (Ach.) Norm. contained isophaeric acid (150) and sphaerophorin 
(148); and that Sphaerophorus melanocarpus (Sw.) DC. contained both 4-0-demethyl-
sphaerophorin ( 149) and sphaerophorin ( 148). 
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Experimental 
The general experimental details have been given previously in Chapter 2. Most 
of the compounds needed for the preparation of the A- and B-ring precursors had been 
prepared previously for Elix35.41,53 ,54, so their preparation was repeated using these 
established, or similar modified methods. 
2-Hydroxy-4-methoxy-6-pentylbenzoic Acid ( 160) 
First ethyl 2,4-dihydroxy-6-pentylbenzoate (155) was monomethylated to form 
ethyl 2-hydroxy-4-methoxy-6-pentylbenzoate (159), as had been described previously. 
Purification on a Si02 column yielded a product with a melting point just above room 
temperature. 
A mixture of ethyl 2-hydroxy-4-methoxy-6-pentylbenzoate (159) (4.6 g), dimethyl 
sulfoxide (50 ml), potassium hydroxide (4.6 g) and water (10 ml) was stirred and heated 
at 90° for 3 h. After cooling the mixture was poured into cold, dilute hydrochloric acid 
and extracted with ether. The ethereal solution was washed with water, with saturated 
brine and dried (MgSOi). Removal of the solvent gave the acid (4.3 g, 100%), which on 
crystallization from dichloromethane-light petroleum afforded 2-hydroxy-4-methoxy-
6-pentylbenzoic acid (160) (1.5 g, 36%) as very fine, colourless needles, m.p. 127° (lit.3~ 
125-126°) (Found: C, 63.8; H, 5.9. Cale. for c22H240g C, 63.5; H, 5.8%). 1H 
n.m.r. (CDCl3) 8 0.92, bt, (CH2)6CH3; 1.10-1.90, m, CH2(CH2)3CH3; 2.95, bt, 
J 7.0 Hz, ArCH2; 3.33, s, OCH3; 6.38, s, ArH x 2; 11.61, vbs, OH and C02H. 
Ethyl 2-Heptyl-6-hydroxy-4-methoxybenzoate (157) 
Ethyl 2-heptyl-4,6-dihydroxybenzoate (154) (7.1 g), dimethyl sulfate (2.5 ml) and 
anhydrous potassium carbonate ( 10 g) were stirred and heated under reflux in acetone (67 
ml) for 22 h. The mixture was poured into cold, dilute hydrochloric acid, extracted with 
ether and the ethereal extract washed with water, with saturated ammonium chloride and 
dried (MgS04). After removal of ether, the crude product was passed through a column 
100 
dried (MgS04). After removal of ether, the crude product was passed through a column 
of silica gel using 2.5% ethyl acetate-light petroleum as eluant. Ethyl 2-heptyl-6-
hydroxy-4-methoxybenzoate (157) (5.9 g, 79%) was obtained as a pale yellow oil from 
the fastest moving fraction. 1 H n.m.r. (CDCI3) 8 0.89, bt, (CH2)6CH3; 1.17-1.60, 
m, CH2(CH2)5CH3 and C02CH2CH3; 2.72-3.05, m, ArCH2; 3.82, s , OCH3; 
4.43, q, J 7.0 Hz, C02CH2CH3; 6.38, s, ArH x 2; 12.00, s, OH. 
2-Heptyl-6-hydroxy-4-methoxybenzoic Acid (158) 
Ethyl 2-heptyl-6-hydroxy-4-methoxybenzoate (157) (6.9 g), dimethyl sulfoxide 
(70 ntl), potassium hydroxide (6.9 g) and water (14 ml) were stirred and heated at 90-94° 
for 4 h. After cooling overnight, the mixture was poured into cold, dilute hydrochloric 
/ 
acid and extracted with ether. The ethereal extract was washed with water, with saturated 
brine and dried (MgS04). Evaporation of the ether gave the acid (5.3 g, 85%). On 
crystallization from cyclohexane 2-heptyl-6-hydroxy-4-methoxybenzoic acid (158) (3.4 
g, 55o/o) formed very fine, almost colourless needles, m.p. 131 ° (lit. 53 129-130°) 1 H 
n.m.r. (CDCl3 + CD3COD3) 8 0.76-1.03, m, (CH2)6CH3; 1.13-1.78, m, 
CH2(CH2)5CH3; 2.98, bt, ArCH2; 3.85, s, OCH3; 6.37, s, ArH x 2; 10.7 and 
12.2, vb, OH and C02H. 
Benzyl 2-Heptyl-4,6-dihydroxybenzoate (164) 
Ethyl 2-heptyl-4,6-dihydroxybenzoate (154) (6.9 g) was added to a solution of 
sodium (0.7 g) in freshly distilled benzyl alcohol (80 ml) under a nitrogen atmosphere. 
The resulting solution was stirred and heated at 130° for 24 h. After allowing to cool, 
the mixture was poured into cold, dilute hydrochloric acid and extracted with ether. The 
ethereal solution was washed with water, with saturated brine and dried (MgS04). After 
evaporation of ether, the excess benzyl alcohol was distilled under reduced pressure. The 
crude product was passed through a column of silica gel using 2.5% ethyl acetate-light 
petroleum as eluant. The second band contained the desired product (6.3 g), which was 
crystallized from light petroleum to give benzyl 2-heptyl-4,6-dihydroxybenzoate (164) 
(5.3 g, 63%) as translucent plates, m.p. 102° (lit.53 94-95°) 1 H n.m.r. (CDCl3) 6 
101 
0.68-1.00, m, (CH2)6CH3; 1.00-1.40, m, CH2(CII2)sCH3; 2.77, bt, ArCH2; 5.37, 
s, OCH2C6H5; 5.77, b, OH; 6.22, 6.31, I 2.5 Hz, H3,5; 7.46, s, OCH2C6HS; 
12.00, s, OH. 
Benzyl 2 ,4-dihydroxy-6-methylbenzoate ( 166) 
This compound was prepared in the same manner as benzyl 2-heptyl-
4,6-clihydroxybenzoate (164), starting from ethyl 2,4-dihydroxy-6-methylbenzoate (156) 
(4.5 g) in a solution of sodium (0.65 g) in benzyl alcohol (74 ml). Benzyl 
2,4-dihydroxy-6-methylbenzoate (166) (3.2 g, 54%) was obtained, from the second band 
to elute from the column, and crystallized in colourless microcrystals, m.p. 140° (lit.41 
137.5-138°). 1 H n.m.r. (CDCl3 + CD3COD3) 8 2.46, s, ArCH3; 5.37, s, 
OCH 2C6H5; 6.23, s, ArH; 7.40, s, OCH2C6H 5; 11.83, s, OH. 
Ethyl 2 ,4-dibenzyloxy-6-methylbenzoate (1.61) 
Anhydrous potassium carbonate (30 g) was added gradually to a solution of ethyl 
orsellinate (156) (7.5 g) and benzyl bromide (9.6 ml) in anhydrous acetone (100 ml) and 
the mixture heated with stirring under reflux for 40 h. Additional benzyl bromide (1.5 
ml) was added when it was apparent from t.l.c. that not all the starting material had 
reacted and heating and stirring continued for a further 24 h. The mixture was poured 
into ice and hydrochloric acid, extracted with ether, the ethereal extract washed with 5o/o 
sodium hydroxide, with water and saturated brine and dried (MgS04). On evaporation 
of the solvent, ethyl 2,4-dibenzyloxy-6-methylbenzoate (161) (41 %) m.p. 84° was 
obtained as colourless crystals 1 H n.m.r. (CDC13) ?· 1.26, t, OCH2CH3; 2.30, s, 
ArCH3; 4.36, q, OCH2CH3; 5.08 (4H), s, OCH2C6H5 x 2; 6.49, s, H3, 5; 7.50, s, 
OCH2C6H5 x 2. 
2,4-Dibenzyloxy-6-methylbenzoic acid (162) 
This acid was obtained by hydrolysis of ethyl 2,4-dibenzyloxy-6-methylbenzoate 
(161) with potassium hydroxide using the method described above for the preparation of 
2-heptyl-6-hydroxy-4-methoxybenzoic acid. 2,4-Dibenzyloxy-6-methylbenzoic acid 
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(162) (98o/o) was obtained as colourless crystals, m.p. 104° (lit.55 m.p. 106°). 1 H n.m.r. 
(CDCI3) 8 2.52, s, ArCH3; 5.07, 5.18, both s, OCH 2c6H 5 x 2; 6.57 s, H3, 5; 
7.58, s, OCH2C6H 5 x 2. 
Synthesis of Depsides-General Procedure 
The appropriate carboxylic acid .Cl mmol) and benzyl ester (1 mmol) were stirred in 
anhydrous toluene ( 4 ml) and trifluoroacetic anhydride (1 ml) until they dissolved and 
then stood at room temperature for 2.5 to 21 h ( until all starting material was consumed as 
indicated by t.l.c.). After removal of the solvent, the residue was purified by 
chromatography on two thick-layer, Si02 plates ( 100 x 20 x 0.1 cm). 15% Ethyl 
acetate-light petroleum was used as eluant, and the major depside ester band developed 
ahead of any unreacted starting material or side products. This band was removed from 
the plate and extracted with hot ethyl acetate. After evaporation of the solvent, the residue 
was crystallized from a suitable solvent. The depside esters so obtained were 
subsequently dissolved in ethyl acetate and stirred with 10% palladium-on-carbon 
(100-300 mg) under an atmosphere of hydrogen for 26 h. The catalyst was filtered, the 
solvent evaporated and the depside crystallized from cyclohexane or carbon tetrachloride. 
Isosphaeric Acid (150) 
Benzyl isophaerate (169) was obtained as a colourless oil (100%) after removal of 
the solvent. 1 H n.m.r. (CDCl3) 8 0.66-1.02, m, (CH2)6CH 3; 1.02-1.43, m, 
CH2(CH2)5CH3; 2.54, s, ArCH3; 2.73-3.10, m, ArCH2; 3.81, s, OCH3; 5.40, s, 
OCH 2C6H 5; 6.34, s, H3, 5; 6.53, 6.70, both d, J 2.5 Hz, H3', 5'; 7.40, s, 
OCH2C6H5. 11.48, 11.72, both s, OH x 2. Mass spectrum mlz 248 (33%), 91 (100). 
' 
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lsosphaeric Acid (150) (77%) crystallized from cyclohexane as colourless needles, 
m.p. 142° (Found: C, 66.4; H, 6.9. c23 H2go7 requires C, 66.3; H, 6.8o/o). 1 H 
n.m.r. (CDCl3 + CD3COD3) 8 0.77-1.03, m, (CH2)6CH 3; 1.03-1.67, m, 
CH2(CH2)5CH3; 2.69, s, ArCH3; 3.00, bt, J 7.0 Hz, ArCH2; 3.90, s, OCH3; 
6.46, s, H3, 5; 6.68, 6.80, both d, J 2.5 Hz, H3', 5'; 11.2, vb, OH and/or C02H. 
Mass spectrum mlz 267 (2.5% ), 266 (15), 249 (7), 248 (18), 222 (19), 207 (30), 
192 (11), 191 (6), 182 (28), 178 (5), 177 (11), 169 (5), 168 (52), 164 (29), 151 
(26), 150 (100), 139 (9), 138 (92), 137 (17), 135 (6), 125 (6), 124 ( 47), 123 (28), 
122 (43), 121 (8), 109 (6), 107 (7). Standard RF values: R F(A) 43; RF(B*) 69; 
RF(C) 53. Observed RT value 9.57 min. The t.l.c.27 and h.p.l.c.57 behaviour of 
synthetic isosphaeric acid (150) was identical with that of a metabolite of a chemical race 
of Dimelaena oriena. 
Hyperlatolic Acid (151) 
Benzyl Hyperlatolate ( 170) (64%) crystallized from n-pentane in colourless, 
needle-like crystals, m.p. 66° (Found: C, 72.3; H, 7.6. C34H4207 requires C, 72.6; H, 
7.5%). l H n.m.r. (CDCl3) 8 0.86, bt, (CH2)4CH3 and (CH2)6CH3; 1.00-1.67, m, 
CH2(CH2)3CH3 and CH2(CH2)5CH3; 2.68-3.10, m, ArCH2 x 2; 3.82, s, OCH3; 
5.38, s, OCH2C6H 5; 6.35, s, H3, 5; 6.53, 6.70, both d, J 2.5 Hz, H3', 5'; 7 .43, s, 
OCH2C6H5. 11.57, 11.70, both s, OH x 2. Mass spectrum mlz 251 (39%), 562 (M+ 
' 
< 0.1 %), 91 (100). 
Hyperlatolic Acid (151) (63%) crystallized from cyclohexane as colourless 
rosettes, m.p. 113° (Found: C, 68.7; H, 7.8. C27H3607 requires C, 68.6; H, 7.7%). 
1H n.m.r. (CDCl3) 8 0.67-1.05, m, (CH2)4CH3 and (CH2)6CH3; 1.05-1.90, m, 
CH2(CH2)3CH3 and CH2(CH2)5CH3; 2.77-3.20, m, ArCH2 x 2; 3.85, s, OCH3; 
6.43, s, H3, 5; 6.69, 6.71, both d, J 2.5 Hz, H3', 5'; 10.92, bs, OH. Mass spectrum 
mlz 455 (1.4%), 454 (6), 238 (1.5), 235 (9), 222 (14), 221 (100), 220 (10), 192 
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(5), 164 (15), 138 (10), 137 (6), 124 (20), 123 (5). Standard RF values: RF(A) 53; 
RF(B*) 74; RF(C) 52. Observed RT value 15.32 min. The t.l.c.27 and h.p.1.c.57 
behaviour of synthetic hyperlatolic acid (151) was identical with that of a metabolite of 
Fuse idea viridis. 
I sohyperlatolic Acid (152) 
Benzyl I sohyperlatolate (171) (53%) crystallized from n-pentane-light petroleum as 
colourless, fine needles, m.p. 87° (Found: C, 72.1; H, 7 .6. C34H4207 requires C, 
72.6; H, 7.5%). l H n.m.r. (CDCl3) 8 0.60-0.97, m, (CH2)4CH3 and (CH2)6CH3; 
0.97-1.63, m, CH2(CH2)3CH3 and CH2(CH2)5CH3; 2.78-3.10, m, ArCH2 x 2; 
3.84, s, OCH3; 5.41, s, OCH2C6H5; 6.40, s, H3, 5; 6.57, 6.75, both d, J 2.5 Hz, 
H3', 5'; 7.49, s, OCH2C6H5. 11.50, 11.65, both s, OH x 2. Mass spectrum mlz 498 
' 
(1.6%) 248 (100). 
I sohyperlatolic Acid ( 152) (94%) crystallized from cyclohexane as colourless 
prisms, m.p. 103° (Found: C, 68.9; H, 7.9. C27H3607 requires C, 68.8; H, 7.7%). 
1H n.m.r. (CDCl3) 8 0.77-1.07, m, (CH2)4CH3 and (CH2)6CH3; 1.07-1.80, m, 
CH2(CH2)3CH3 and CH2(CH2)5CH3; 2.78-3.22, m,_ ArCH2 x 2; 3.83, s, OCH3; 
6.38, s, H3, 5; 6.63, 6.77, both d, J 2.5 Hz, H3', 5'; 11.00, vb, OH x 2. Mass 
spectrum mlz 454 (2.7%), 267 (5), 266 (33), 249, (12), 248 (41), 224 (35), 222 
(17), 207 (10), 206 (64), 205 (7), 192 (26), 191 (16-), 183 (7), 182 (71), 181 (8), 
180 (18), 179 (6), 178 (29), 177 (32), 168 (29), 165 (10), 164 (76), 163 (20), 151 
(24 ), 150 ( 69), 149 (9), 139 (9), 138 ( 100), 137 (28), 136 (8), 135 (16), 125 (8), 
124 (61), 123 (20), 122 (21), 121 (17), 108 (6), 107 (8). Standard RF values: 
RF(A) 48; Rp(B*) 79; RF(C) 52. Observed RT value 15.38 min. The t.l.c.27 and 
h.p.l.c.57 behaviour of synthetic isohyperlatolic acid (152) was identical with that of a 
minor metabolite of Fuscidea viridis. 
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Superlatolic Acid (153) 
Benzyl Superlatolate (172) (68%) crystallized from n-pentane as fine colourless 
crystals, m.p. 66° (Found: C, 73.0; H, 8.0. C36H4607 requires C, 73.2; H, 7.8%). 
l H n.m.r. (CDCI3) 8 0.83, 0.86, both bt, (CH2)6CH 3 x 2; 1.14, 1.25, both m, 
CH2(CH2)5CH3 x 2; 2.50-2.90, m, ArCH2 x 2; 3.82, s, OCH3; 5.39, s, 
OCH 2C6H 5; 6.36, s, H3, 5; 6.54, 6.60, both d, J 2.5 Hz, H3', 5'; 7.40, s, 
OCH2C6H 5· 11.33, 11.47, both s, OH x 2. 
' 
Superlatolic acid (153) (89%) crystallized from cyclohexane as a colourless 
powder, m.p. 114° (lit.53 93-94°) (Found: C, 69.1; H, 8.2. Cale. for C29H4007: C, 
69.6; H, 8.1%). 1H n.m.r. (CDCl3) 8 0.90, br t, (CH2)6CH3 x 2; 1.08-1.80, m, 
CH2 (CH 2)3CH3 x 2; 2.82-3.26, m, ArCH2 x 2; 3.90, s, OCH3; 6.50, s, H3, 5; 
6.78, 6.89, both d, J 2.5 Hz, H3', 5'. Mass spectrum mlz 266 (1.3%), 222 (17), 208 
(7), 164 (5), 151 (15), 139 (10), 138 (100), 137 (23), 125 (5), 124 (40), 123 (11), 99 
(13). Standard RF values: RF(A) 53; RF(B*) 80; RF(C) 56. Observed RT value 
24.64 min. 
Sphaerophorin (148) 
Benzyl 2-0-benzylsphaerophorinate (167) (39%) crystallized from cyclohexane as 
colourless crystals, m.p. 98° (Found: C, 73.9; H, 7.1. E37H4007 requires C, 74.5; H, 
6.8%). l H n.m.r. (CDCI3) 8 0.70-1.00, m, (CH2)6CH 3; 1.00-1.70, m, 
CH2(CH2)5CH3; 2.42, s, ArCH3; 2.60-2.90,m, ArCH2; 3.82, s, OCH3; 5.13, 
5.41, both s, OCH2C6H5 x 2; 6.47, s, H3, 5; 6.48, 6.72, both d, J 2.5 Hz, H3', 5'; 
7.50, s, OCH2C6H5. 11.62, s, OH. Mass spectrum mlz 596 (M<0.1 %) 255 (100). 
. ' 
Sphaerophorin (148) (74%) crystallized from carbon tetrachloride as colourless 
needles, m.p. 141°(lit. 12 137°) (Found: C, 66.0; H, 7.0. Cale. for C23H2807: C, 66.3; 
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H, 6.8o/o). l H n.m.r. (CDCI3/CD3COCD3) 8 0.88, br t, (CH2)6CH3; 1.20-1.54, m, 
CH2(CH2)5CH3; 2.67, s, ArCH3; 2.90-3.22, m, ArCH2; 3.88, s, OCH3; 6.46, s, 
H3, 5; 6.78, s, H3', 5'; 11.50, vb s, OH x 2. Mass spectrum mlz 270 (0.02%), 208, 
(16), 138 (36), 137 (17), 124 (100), 123 (23), 109 (10), 108 (5), 107 (12). Standard 
RF values: RF(A) 45; RF(B*) 74; RF(C) 55. Observed RT value 9.45 min. This 
synthetic sphaerophin (148) was identical with a natural sample isolated from 
Sphaerophorus melanocarpus (m.p., m.m.p., t.1.c., h.p.1.c., m.s.) and was also detected 
in Dimelaena oriena. 
4-0-Demethylsphaerophorin (149) 
Benzyl 2,4-di-O-benzyl-4-0-demethylsphaerophorinate (168) (86%) was obtained 
as a colourless oil (Found: C, 77.3; H, 7.1. C43H4407 requires C, 76.8; H, 6.6%). 
1 H n.m.r. (CDCI3) 8 0.75-1.00, m, (CH2)6CH3; 1.00-1.44, m, CH2(CH2)5CH3; 
2.41, s, ArCH3; 2.60-2.90,m, ArCH2; 5.10, 5.41, both s, OCH2C6H5 x 2; 6.55, s, 
H3, 5; 6.47, 6.72, both d, J 2.5 Hz, H3', 5'; 7.50, s, OCH2C6H 5; 11.63, s, OH. 
Mass spectrum mlz 343 (1.7%) 91 (100). 
4-0-Demethylsphaerophorin (149) (69%) crystallized from carbon tetrachloride as 
colourless, fine needles, m.p. 136° (Found: C, 65.8; H, 6.4. C22H2607 requires C, 
65.7; H, 6.5%). 1 H n.m.r. (CDCl3/CD3COCD3) 8 0.80-1.00, m, (CH2)6CH3; 
1.20-1.50, m, CH2(CH2)5CH3; 2.61, s, ArCH3; 3.05, br t, ArCH2; 6.40, s, H3, 5; 
6.60, 6.74, both d, J 2.5 Hz, H3', 5'; 11.50, vb s, OH. Mass spectrum n1/z 340 
(0.01 %), 208, (12), 150 (5), 137 (10), 124 (100), 123 (28). Standard RF values: 
RF(A) 38; RF(B*) 57; RF(C) 33. Observed RT value 5.92 min. The t.1.c.27 and 
h.p.1.c.57 behaviour of synthetic 4-0-demethylsphaerophorin (149) was identical with 
that of a minor metabolite of Sphaerophorus melanocarpus. 
107 
References 
1. Mosbach, K., Angew. Chem. internat. Edit., 1969, 8, 240. 
2. Hale, M. E., Jr., "The Biology of Lichens, 3rd Ed., (Edward Arnold (Publishers) 
Ltd.: London 1983). 
3. Rundel, P. W., Biochemical Systematics and Ecology, 1978, 6, 157. 
4. Iskander, I. K. and Syers, J. K., J. Soil Sci., 1972, 23, 255. 
5. Burkholder, P. R., Evans, A. W., McVeigh, I. and Thornton, H. K., Proc. natn. 
Acad. Sci. U. S. A. , 1944, 30, 250. 
6. Ahmadjian, V. and Hale, M. E., "The Lichens" (Acaadernic Press, Inc.: New 
York 1973). 
7. Moxham, T. H., British Lichen Society Bulletin, 1980, 47, 1. 
8. Zopf, W ., "Die Flechtenstoffe in chemischer, botanischer, pharmakologischer 
und technischer Beziehung" (Gustav Fischer: Jena 1907). 
9. Hesse, 0., "Flechtenstoffe", Biochemisches Handlexikon (Ed. Abdehalden 
1912). 
10. Fischer, E. and Fischer, H., Ber., 1913, 46, 1138. 
11. Asahina, Y. and Shibata, S., "Chemistry of Lichen Substances" (Japanese 
Society for the Promotion of Science: Tokyo 1954; reprint Asher; Amsterdam 
1971 ). 
12. Culberson, C. F., "Chemical and Botanical Guide to Lichen Products" (The 
University of North Carolina Press: Chapel Hill 1 ~69). 
13. Elix, J. A., Whitton, A. A. and Sargent, M. V ., "Recent Progress in the 
Chemistry of Lichen Substances" Progress in the Chemistry of Organic 
Natural Products, 1984, 45, 103. 
14. Culberson, C. F., Nash, T. H. and Johnson, A., Bryologist, 1979, 82, 154. 
15. Birch, A. J. and Donovan, F. W., Aust. J. Chem. , 1953, 6, 360. 
16. Gatenbach, S. and Mosbach, K., Acta Chem. Scand., 1959, 13, 1561. 
17. Mosbach, K., Acta Chem. Scand., 1960, 14, 457. 
108 
18. Richardson, D. H. S., Smith, D. C. and Lewis, D. H., Nature, 1967, 214, 879. 
19. Yamazaki, M., Matsuo M., and Shibata, S., Chem. Pharm. Bull., 1965, 13, 
1015. 
20. Yamazaki, M. and Shibata, S., Chem. Pharm. Bull., 1966, 14, 96. 
21. Elix, J. A. and Gaul, K. L., Aust. J. Chem., 1986, 39, 613. 
22. Barton, D. H. R. and Cohen, T., Festschrift A. Stoll, Birkhauser, Basel, 1957, 
117. 
23. Sala, T. and Sargent, M. V., J. Chem. Soc., Perkin Trans. 1, 1981, 855. 
24. Elix, J. A., Jenie, U. A. and Parker, J. L., Aust. J. Chem., 1987, 40, 1451. 
25. Fujii, K. and Osumi, S., J. Pharm. Soc. Japan, 1936, 56, 101. 
26. Molho, L., Bodo, B. and Molho D., Phytochemistry, 1979, 18, 2049. 
27. Culberson, C. F., J. Chromatography, 1972, 72, 113. 
28. Culberson, C. F., Hale, M. E., Jr.; T¢nsberg, T. and Johnson, A., Mycologia, 
1984, 76, 148. 
29. Culberson, C. F. and Johnson, A., J. Chromatography, 1976, 128, 253. 
30. Culberson, C. F. and Culberson, W. L., Systematic Botany, 1976, 1, 325. 
31. Elix, J. A., Wilkins, A. L. and Wardlaw, J. H., Aust. J. Chem., 1987, 40, 
2023. 
32. Sundholm, E.G. and Huneck, S., Chimica Scripta , 1980, 16, 197. 
33. Sundholm, E.G. and Huneck, S., Chimica Scripta, 1981, 18, 233. 
34. Nicollier, G., Rebetz, M. and Tabacchi, R., Helv. Chim. Acta, 1979, 62, 711. 
35. Elix, J. A., Aust. J. Chem., 1974, 27, 1767. 
36. Elix, J. A., Engkaninan, U., Jones, A. J., Raston, C. L., Sargent, M. V. and 
White, A. H., Aust. J. Chem., 1978, 31, 2057. 
37. Ferguson, B. A., PhD thesis, A. N. U., 1977. 
38. Brown, C. J., Clark, D. E., Ollis, W. D. and Veal, P. L , Proc. Chem. Soc., 
1960. 393. 
39. Neelakantan, S., Padmasani, R. and Seshadri, T. R., Tetrahedron, 1965, 21, 
3531. 
40. Elix, J. A. and Norfolk, S., Aust. J. Chem., 1975, 28, 399. 
109 
41. Elix, J. A. and Norfolk, S., Aust. J. Chem ., 1975, 28 , 1113. 
42. Elix, J. A., Mahadevan, I., Wardlaw, J. H., Arvidsson, L. and J¢rgensen, P. M., 
Aust. J. Chem. , 1987, 40, 1581. 
43 . Santesson, J., Acta Chem. Scand., 1970, 24, 3373. 
44. De la Mare, P. B. D. and Swedlund, B. E., "The Chemistry of the Carbon-
Halogen Bond", pt. 1, p 490, (Ed. Patai, S., John Wiley & Sons, Inc .,New 
York, 1973). 
45. Morrison, R. T. and Boyd, R. N., "Organic Chemistry", 5th Ed., p 504, (Allyn 
and Bacon, Inc., Boston, 1987). 
46. Elix, J. A. and Lajide, L., Aust. J. Chem., 1984, 37, 2153. 
47. Sala, T. and Sargent, M. V., J. C. S. Perkin!, 1981, 877. 
48. Emmons, W. D., McCallum, K. S. and Ferris, A. F., J. Amer, Chem. Soc., 
1953, 7 5, 6047. 
49. Bourne, E. J., Stacey, M., Tatlow, J. C. and Worrall, R., J. Chem. Soc., 1954, 
2006. 
50. Parish, R. C. and Stock, L. M., J. Org. Chem ., 1965, 30, 927. 
51. Hamilton, R. J. and Sargent, M. V., J. C. S. Perkin I, 1976, 943. 
52. Anygal, S. J., Org. React., 1954, 8, 197. 
53. Elix, J. A., Jones, A. J., Lajide, L., Coppins, B. J. and James, P. W., Aust. J . 
Chem., 1984, 37, 2349. 
54. Dyke, H. J., Elix, J. A., Marcuccio, S. M. and Whitton, A. A., Aust. J. Chem. , 
1987, 40, 431. 
55. Manaktala, S. K., Neelakantan, S. and Seshadri, T. R., Tetrahedron, 1966, 22, 
2373. 
56. Elix, J. A. and Wardlaw, J. H., Aust. J. Chem., 1987, 40, 425. 
57. Lumbsch, H. T. and Elix, J. A., Plant Syst. Evol., 1985, 150, 275. 
